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Abstract 
Although the persistent pesticide DDT has been banned or restricted since the 1970s, DDT 
and its metabolites may still pose a hazard to wildlife and humans. There is a growing concern 
regarding endocrine disruptors and their potential role in negative trends in male reproductive 
health. The aim of this study was to investigate the effects of two DDT metabolites, 3-
MeSO2-DDE and o,p’-DDD, and the synthetic DDE analogue 3,3’-(bis)MeSO2-DDE on 
mammalian male reproductive system by evaluate the effect on testicular steroidogenesis in 
LH-stimulated neonatal porcine Leydig cells in vitro. The test compounds are known to 
disrupt steroidogenesis and cause toxicity in the adrenal cortex of several species, and o,p’-
DDD is used in the treatment of adrenocortical cancer in humans. 3-MeSO2-DDE has been 
suggested as an alternative drug and 3,3’-(bis)MeSO2-DDE might reveal any structure-
specific effects regarding methylsulfonyl moiety on the steroidogenesis. Testicles were 
obtained from routine castrations of neonatal piglets and Leydig cells were isolated and 
purified using a discontinuous Percoll gradient. The primary cultures of Leydig cells were 
stimulated with LH and exposed to the test compounds for 48 hours in six increasing 
concentrations (0-20 µM). Cell viability was assessed and the production of testosterone, 
estradiol, progesterone and cortisol was measured from the cell medium. Gene expression 
analysis was performed on 16 genes involved in testicular Leydig cell steroidogenesis. The 
results showed that both 3-MeSO2-DDE and o,p’-DDD were cytotoxic at the highest 
concentration (20 µM), whereas 3,3’-(bis)MeSO2-DDE had no effect on cell viability. All 
three test compounds decreased LH-stimulated production of testosterone, estradiol and 
progesterone by the Leydig cells in a concentration-dependent manner. No detectable levels 
of cortisol were obtained. The gene expression analysis suggested a general suppression in 
mRNA levels of several genes involved in steroidogenesis induced by all three test 
compounds. However, the compounds reduced expression of slightly different genes. The 
decreased expression of some genes involved in steroidogenesis might be associated with the 
reduced hormone production in exposed cells. This study suggests a steroidogenic disruption 
in porcine Leydig cells induced by the test compounds. The suppression of Leydig cell 
steroidogenesis by the two DDT metabolites might be of concern regarding negative effects 
on male reproduction. 
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Abbreviations  
3-MeSO2-DDE 2-(3-methylsulfonyl-4-chlorophenyl)-2-(4-
chlorophenyl)-1,1-dichloroethene 
3,3’-(bis)MeSO2-DDE 2,2’-bis(3-methylsulfonyl-4-chlorophenyl)-1,1-
dichloroethene 
3βHSD 3β-hydroxysteroid dehydrogenase 
17βHSD 17β-hydroxysteroid dehydrogenase 
ACC Adrenocortical carcinoma 
AKRIC4 aldo-keto reductase family 1, member C4 
cAMP Cyclic adenosine monophosphate 
cDNA Complementary DNA 
CT Cycle threshold 
CYP11A1 Cholesterol side-chain cleavage enzyme 
CYP11B1 11β-hydroxylase 
CYP17A1 Cytochrome P450 c17 
CYP19A1 Aromatase 
CYP21 21-hydroxylase 
CYP51 lanosterol 14α-demethylase 
DAX-1 dosage-sensitive sex reversal-adrenal hypoplasia 
congenita critical region on the X chromosome, 
gene 1 
DDD Dichlorodiphenyldichloroethane 
DDE Dichlorodiphenyldichloroethylene 
DDT Dichlorodiphenyltrichloroethane 
DEPC Diethylpyrocarbonate 
DMSO Dimethyl sulfoxide 
H295R Human adrenocortical cell line 
hCG Human chorionic gonadotropin 
HMGR 3-hydroxy-3-methyl-glutaryl-CoA reductase 
LH Lutenizing hormone 
Ml Milliliter 
Ng Nanogram 
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o,p’-DDD 1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-
dichloroethane 
PCR polymerase chain reaction 
Pg Picogram 
POPs Persistent organic pollutants 
Ppb Parts per billion 
RIA Radioimmunoassay  
RNA Ribonucleic acid 
RPM Revolutions per minute 
RT Reverse transcriptase 
SF-1 Steroidogenic factor 1 
StAR Steroidogenic acute regulatory protein  
TBT Tributyltin chloride 
Y-1 Mouse adrenocortical cell line 
 
 
 
 
 
 
 
 
 
 
9 
  
1. Introduction 
In the present study the DDT metabolites 2-(3-methylsulfonyl-4-chlorophenyl)-2-(4-
chlorophenyl)-1,1-dichloroethene (3-MeSO2-DDE) and 1-(2-chlorophenyl)-1-(4-
chlorophenyl)-2,2-dichloroethane (o,p’-DDD) and the synthetic DDE analogue 2,2’-bis(3-
methylsulfonyl-4-chlorophenyl)-1,1-dichloroethene (3,3’-(bis)MeSO2-DDE) were 
investigated for possible endocrine effects on testicular Leydig cell steroidogenesis.  
 
1.1 Endocrine disrupting chemicals 
The release of persistent organic pollutants (POPs) into the environment has been ongoing for 
several decades mainly as a consequence of industrial by-products and agricultural 
productivity. Their persistency to degradation and lipophilic nature make them biomagnifies 
in food chains and reach high concentrations in adipose tissue of top predators. There is a 
growing concern regarding several POPs as they might be capable of modulating or disrupting 
the endocrine system both in wildlife and humans (Colborn et al., 1993; Tyler et al., 1998; 
Vos et al., 2000). Alteration of endocrine function caused by endocrine disruptors might 
include several mechanisms, such as interference with synthesis, secretion, action, or 
elimination of natural hormones in the body (Vos et al., 2000). As hormones play a key role 
in many vital functions, including sexual development and regulation of fertility, the 
endocrine disrupting chemicals might have adverse effects on reproduction and male fertility 
(Eertmans 2003). The endocrine disruptors might act as modulators of sex steroid synthesis 
by interacting with estrogen and/or androgen receptors to act as agonists or antagonists of 
hormones or by modulate the activity and/or expression of steroidogenic enzymes (Whitehead 
2006). 
 
1.2 DDT  
One compound of concern is the organochlorine pesticide dichlorodiphenyltrichloroethane 
(DDT) which belongs to the group of halogenated organic compounds consisting of a 
backbone of hydrocarbons where hydrogen is substituted with chlorine to varying degrees. 
The use of DDT started in the 1940s and it revolutionized agricultural production and 
prevented people from being infected with insect-borne diseases, like malaria and typhus. 
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DDT is a mixture of several chemicals, but it mostly consist of the isomers o,p’-DDT and 
p,p’-DDT (Haller et al., 1945; Thomas et al., 2008). DDT is extremely hydrophobic, 
chemically very stable and is slowly degraded in nature and is mainly broken down to the 
persistent metabolites dichlorodiphenyldichloroethylene (DDE) and 
dichlorodiphenyldichloroethane (DDD) in the environment (Jonsson et al., 1994) which may 
undergo further biotransformation. The persistency and lipophilic properties make DDT and 
its metabolites bioaccumulate in body fat and magnify through food chains and accumulate in 
higher mammals, also in arctic animals (Norstrom and Muir, 1994). DDT and its metabolites 
have shown weak estrogen and endocrine disruptor effect, causing deleterious effects on 
reproduction in wildlife (Brandt et al., 1998; Colborn et al., 1993; Guillette et al., 1994; Heath 
et al., 1969; Sharpe, 1995; Whitehead and Rice, 2006). In addition, the main metabolite p,p’-
DDE is a potent anti-androgen (Kelce et al., 1995). Even though it has been banned or 
restricted many places since the 1970s, DDT is still used in large quantities in countries for 
malaria control (Dua et al., 1996; Longnecker, 2005; van den Berg, 2009). Due to the 
persistency in the environment and the long-distance atmospheric transportation (Wang et al., 
2010) the levels of these persistent organic pollutants are long lasting and may still pose a 
hazard to wildlife and humans (Crinnion, 2009).  
 
1.3 DDT metabolites and adrenal toxicity 
In addition to be potential endocrine disruptors causing reproductive impairment, some DDT 
metabolites, like 3-MeSO2-DDE and o,p’-DDD inhibit steroidogenesis and are toxic to the 
adrenal cortex of several species (Asp et al., 2009; Brandt et al., 1992; Jonsson et al., 1994). 
DDT metabolite o,p’-DDD is a well known drug in the treatment of adrenocortical carcinoma 
(ACC) in humans, but due to low efficiency and negative side effects there is a need for 
treatment alternatives. The mechanisms by which o,p’-DDD cause adrenal toxicity is not fully 
understood, but it might interfere with several steroidogenic enzymes, including cholesterol 
side-chain cleavage enzyme (CYP11A1) and11ß-hydroxylase (CYP11B1)(Hart and Straw, 
1971; Martz and Straw, 1980). The main DDT metabolite p,p’-DDE may be transformed to 3-
MeSO2-DDE in mammals and 3-MeSO2-DDE undergoes bioactivation by CYP11B1 and 
cause toxic effects in the adrenal cortex of several species (Brandt et al., 1992; Lindstrom et 
al., 2008; Lund et al., 1988). Therefore, 3-MeSO2-DDE has been proposed as an alternative 
drug for treatment of ACC in humans (Lindhe et al., 2002). With major species differences 
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with regard to adrenocortical toxicity and CYP-dependent covalent binding of both 3-MeSO2-
DDE and o,p’-DDD (Brandt et al., 1992) further knowledge about these compounds is 
needed. As the adrenocortical effects of 3-MeSO2-DDE have shown to be structure-specific, 
synthetic DDE analogue 3,3’-(bis)MeSO2-DDE might reveal any structural requirements for 
steroidogenic effects depending on the methylsulfonyl moiety. Both adrenal glands and 
gonads are potential targets for endocrine disruption as adrenal cells and Leydig cells possess 
steroidogenic activity. Whereas adrenal cortex mainly produces corticosteroids, the hormone 
producing Leydig cells is involved in androgen and estrogen biosynthesis. The difference is 
the specific expression of CYP11B1 and 21-hydroxylase (CYP21) involved in the synthesis 
of cortisol and corticosterone in the adrenal cortex. However, the difference might be limited 
as testis of mice and humans express these enzymes (Hu et al., 2007; Pezzi et al., 2003) 
making Leydig cells a good model for studying endocrine effects of the adrenal toxicants. 
 
1.4 Neonatal porcine Leydig cells 
The endocrine changes of hormones regulate testicular function during development and the 
pig testes have a remarkable steroid production (Raeside et al., 2006). The testes are divided 
into the vascularized interstitial tissue including Leydig cells, macrophages, lymphatic vessels 
and connective tissue, and the seminoferous tubules which contain Sertoli and germ cells 
(Gnessi et al., 1997) (Figure 1.1). Leydig cells are found adjacent to the seminoferous tubules 
and are the steroid hormone producing cells in the interstitial tissue (van Straaten and 
Wensing, 1978). Leydig cells are stimulated by the pituitary hormone luteinizing hormone 
(LH) which is the main physiological hormonal stimulator of testosterone biosynthesis by 
Leydig cells (Colenbrander et al., 1977; Colenbrander and Van Straaten, 1977). The testicular 
steroidogenesis is dependent on both acute and chronic stimulating effects of gonadotropin 
LH, including transport and conversion of cholesterol to pregnenolone via the cyclic 
adenosine monophosphate (cAMP)-pathway and increase of steroidogenic enzyme activity 
(Lejeune et al., 1998a; Mather et al., 1981). In vitro studies confirm the stimulating effect of 
LH on porcine Leydig cell steroidogenesis (Bernier et al., 1983; Geiger et al., 1999; Lejeune 
et al., 1998b)  
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Figure 1.1: Schematic overview over the mammalian testes (rat) and the different 
compartments, including Leydig cells (from Gnessi et al. 1997) 
 
Pig Leydig cell development occurs in three distinct waves, with the second perinatal wave of 
development being additional compared to other mammals, only human testes have a similar 
thriphasic pattern (Prince, 2001; Raeside et al., 2006; van Straaten and Wensing, 1978). The 
first developmental phase of porcine Leydig cells occurs during fetal life (van Vorstenbosch 
et al., 1984). The second, perinatal wave of Leydig cell development is between 
approximately 90 days of gestation to about three weeks after birth when a large volume of 
well differentiated Leydig cells develops, with active steroid synthesis and secretion in the 
first weeks after birth (Colenbrander et al., 1978; van Straaten and Wensing, 1978). In the 
neonatal pig, the majority of the testicular volume, and the percentage of cells, are Leydig 
cells (van Straaten and Wensing, 1977). During the perinatal phase of development there is a 
rise in LH and testosterone levels (Colenbrander et al., 1978; Colenbrander et al., 1977). The 
third wave of development starts just prior to puberty at 13 weeks after birth (van Straaten and 
Wensing, 1978). Pig testes also produce large amounts of estrogens, and although 
concentrations of androgens are higher, estrogen concentrations peak during neonatal 
development in male pigs (Ford, 1983; Raeside et al., 1989). Altogether, neonatal porcine 
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Leydig cells have an active steroidogenesis with high levels of testosterone and estradiol 
during the neonatal period associated with highly assessable LH stimuli (Colenbrander and 
Van Straaten, 1977; Schwarzenberger et al., 1993; Wagner and Claus, 2008). The 
steroidogenic activity and hormone secretion of neonatal pig Leydig cells is maintained in 
culture (Mather et al., 1981).  
 
1.5 Aim of Study 
DDT and its metabolites DDE and DDD are persistent organic pollutants in the environment 
and may pose a hazard to wildlife and humans, including their endocrine effect on the male 
reproductive system. In the present study the effect of the DDT metabolites 3-MeSO2-DDE 
and o,p’-DDD and the synthetic DDE analogue 3,3’-(bis)MeSO2-DDE was investigated on 
the testicular Leydig cell steroidogenesis in vitro. Neonatal porcine Leydig cells possess full 
testicular steroidogenesis which is maintained in culture and stimulated by LH. The 
compounds investigated in the present study have previously been demonstrated to cause 
endocrine disrupting effects in the adrenal cortex and are involved in research for 
improvement of adrenal cancer medicine. In addition to screen for potential endocrine effects 
on male reproductive function, further knowledge about the compounds steroidogenic effect 
might contribute to improved therapy of ACC in humans. The main aim was to clarify 
possible endocrine disrupting effects of 3-MeSO2-DDE, 3,3’-(bis)MeSO2-DDE and o,p’-DDD 
on mammalian male reproductive system by evaluate the effect on testicular steroidogenesis 
in LH-stimulated neonatal porcine Leydig cells. In order to evaluate the compounds potential 
effect on testicular steroidogenesis, neonatal Leydig cells was obtained from pig testicles to 
 Quantify the toxicants effect on cell viability 
 Quantify the effect on production of testosterone, estradiol, progesterone and 
cortisol by the Leydig cells 
 Quantify the effect on expression of 16 genes coding for enzymes involved in 
Leydig cell steroidogenesis  
Parallel with the study presented here, exposure to the test compounds was performed on 
unstimulated (without LH) porcine Leydig cells. 
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1.6 Background 
1.6.1 Test compounds 
 
3-MeSO2-DDE 
The DDE metabolite 3-MeSO2-DDE (Figure 1.2) was first discovered in the blubber of Baltic 
grey seals, and has been isolated from several tissues of mammals (Bergman et al., 1994; 
Jensen and Jansson, 1976; Letcher et al., 1995). DDE is slowly transformed to 3-MeSO2-DDE 
in mammals by glutathione conjugation (Preston et al., 1984) and further metabolism in the 
mercapturic acid pathway (Bakke et al., 1982; Brandt et al., 1992). Due to its persistency and 
lipophilic properties, 3-MeSO2-DDE is found in parts per billion (ppb) amounts in human 
tissues like liver and adipose tissue, and in breast milk (Chu et al., 2003; Noren and 
Meironyte, 2000; Weistrand and Noren, 1997). The endocrine disrupting effects of 3-MeSO2-
DDE have been reported in adrenal cortex of several species, mice being most sensitive 
(Lindstrom et al., 2008). 3-MeSO2-DDE undergoes bioactivation to a reactive intermediate by 
the steroidogenic enzyme CYP11B1 and cause formation of irreversible bound protein 
adducts, cell death and decreased corticosterone production in the adrenal cortex of mice in 
vivo (Jonsson et al., 1991; Lund et al., 1988; Lund and Lund, 1995). Toxicity and irreversible 
binding of 3-MeSO2-DDE have also been reported in vivo in chicken (Jonsson et al., 1994). 3-
MeSO2-DDE cause cytotoxicity and decreased corticosterone production in mouse adrenal 
cells in vitro (Asp et al., 2009). In addition, the in vitro bioactivation of 3-MeSO2-DDE in the 
human adrenal gland suggests that it might be an adrenal toxicant in humans (Jonsson and 
Lund, 1994). Hence, 3-MeSO2-DDE has been proposed as an alternative drug for treatment of 
ACC and Cushing’s syndrome; an overproduction of glucocorticoids due to a pituitary tumor 
(Lindhe et al. 2002).  
 
3,3’-(bis)MeSO2-DDE 
3,3’-(bis)MeSO2-DDE (Figure 1.2) is a synthetic and structural related compound to 3-
MeSO2-DDE, but no toxicity or irreversible binding of 3,3’-(bis)MeSO2-DDE is reported in 
mice adrenal cortex in vivo (Lund et al., 1988). However, the compound decreased 
corticosterone production and produced CYP11B1-dependent cytotoxicity in mice 
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adrenocortical cells in vitro, although less potent than 3-MeSO2-DDE (Asp et al., 2009). The 
bioactivation and toxicity of 3-MeSO2-DDE in the adrenal cortex is demonstrated to be 
structure-specific and dependent on the methylsulfonyl group (Asp et al., 2009; Hermansson 
et al., 2007; Lund and Lund, 1995). Therefore, 3,3’-(bis)MeSO2-DDE might elucidate any 
structural requirements of the test compounds effect on Leydig cell steroidogenesis.  
 
o,p’-DDD 
The DDD isomer o,p’-DDD (Figure 1.2) was first observed to be selectively toxic to the 
adrenal cortex of dogs, with bioactivation of the side chain to a reactive acyl chloride that 
induces cell death, decreases glucocorticoid synthesis and produces irreversibly bound protein 
adducts (Hart et al., 1973; Martz and Straw, 1977; Martz and Straw, 1980; Nelson and 
Woodard, 1949). The adrenocortical toxic effects of o,p’-DDD has also been reported in vivo 
in chicken (Jonsson et al., 1994) and o,p’-DDD binds to mouse lung tissue both in vivo and in 
vitro (Lund et al., 1989; Lund et al., 1986). o,p’-DDD is a well known adrenocorticolytic 
compound which is used to treat ACC and Cushing’s syndrome in humans (Ahlman et al., 
2001; Newell-Price et al., 2006) and has been proposed to interact with several steroidogenic 
enzymes, including CYP11A1 and CYP11B1(Asp et al., 2009; Martz and Straw, 1980). 
However, the enzyme(s) responsible for bioactivation and the mechanism by which o,p’-DDD 
block glucocorticoid synthesis in the adrenal cortex is still unknown (Ahlman et al., 2001; Cai 
et al., 1997; Hart et al., 1973; Stigliano et al., 2008). Not all ACC patients respond to o,p’-
DDD treatment and it also produces gastrointestinal and neurotoxic side effects (Ahlman et 
al., 2001; Allolio and Fassnacht, 2006). Therefore, treatment alternatives are needed and 3-
MeSO2-DDE might be an alternative drug.  
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Figure 1.2: Chemical structures of the test compounds used in this study (from Asp et al. 
2009). 
 
1.6.2 Steroidogenesis in porcine Leydig cells 
The active steroidogenesis and significantly production of steroid hormones by Leydig cells 
during the neonatal period involves the activity of numerous enzymes in a rather complex 
pathway (Figure 1.3). Steroidogenic acute regulatory protein (StAR) is involved in 
transporting cholesterol from the outer to the inner mitochondrial membrane as the first rate-
limiting step of steroidogenesis (Christenson and Strauss, 2000; Privalle et al., 1983; Stocco, 
2001). Further, CYP11A1 initiate the steroid synthesis by converting cholesterol to 
pregnenolone (Miller, 1995). The biosynthesis of testosterone and estradiol can then be 
carried out through two different pathways; Δ4 pathway via progesterone and 17α-
hydroxypreogesterone, or by Δ5 pathway via 17α-hydroxypregnenolone and 
dehydroepiandrosterone (DHEA) (Conley and Bird, 1997). The Δ5 pathway is predominant in 
testes of pigs and humans (Ruokonen and Vihko, 1974) which make pig testes a good model 
for testicular steroidogenesis. 3β-hydroxysteroid dehydrogenase (3β-HSD)(Clark et al., 1996) 
and cytochrome P450 c17 (CYP17A1)(Sasano et al., 1989) are both involved in the Δ5 
pathway, and CYP17A1 catalyzes both 17α-hydroxylase and 17,20 lyase activity (Nakajin et 
al., 1981) to convert pregnenolone into testosterone and estradiol precursors in neonatal pig 
testes. Together with cytochrome b5 (CYB5), CYP17A1 make up the andien-β synthase 
enzyme system which catalyze the metabolism of pregnenolone to androstadienol (Meadus et 
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al., 1993; Nakajin et al., 1985). In addition, the interaction between CYP17A1 and CYB5 is 
important to the 17,20 lyase activity (Hall, 1991). The last step in formation of testosterone is 
catalyzed by 17β-hydroxysteroid dehydrogenase (17β-HSD) enzymes, which is a large family 
of enzymes with several forms (Inano et al., 1981). One of them, 17β-HSD4 is involved in 
inactivation of estradiol to estrone (Adamski et al., 1992; Adamski et al., 1995) whereas 17β-
HSD1 catalyze the reverse reaction. The synthesis of estrogens from androgens is catalyzed 
by the enzyme aromatase (CYP19A1) (Conley et al., 1996). One of the enzymes belonging to 
the cytosolic aldo-keto reductases (AKR1C4) have been reported to convert active androgens 
and estrogens into their associated inactive metabolites (Penning et al., 2000).  
HMG-CoA reductase (HMGR) and lanosterol 14α-demethylase (CYP51) are important 
enzymes involved in the cholesterol biosynthesis pathway (Debeljak et al., 2003; Rodwell et 
al., 1976). Ferritin light polypeptide (FTL) is part of ferritin, an iron storage protein which 
plays a central role in numerous essential cellular functions (Hentze and Kuhn, 1996). The 
transcription factor steroidogenic factor 1 (SF-1; coded by NR5A1) is involved in regulation 
of several steroidogenic genes, including StAR, CYP11A1, CYP17A1 and CYP19A1 (Moe et 
al., 2007; Sadovsky and Dorn, 2000; Sugawara et al., 1996). The activity of SF-1 might be 
counteracted by another transcription factor, the dosage-sensitive sex reversal-adrenal 
hypoplasia congenita critical region on the X chromosome, gene 1 (DAX-1; coded by 
NR0B1) (Ikeda et al., 1996; Yu and Li, 2006).  
 
The steroidogenic output is similar in steroidogenic cells of the adrenal cortex and the 
testicular Leydig cells. They might share a common origin (Hatano et al., 1996) and adrenal-
like cells might migrate into the testes during development (Val et al., 2006).  The difference 
is the specific expression of CYP11B1 and CYP21 involved in the synthesis of cortisol and 
corticosterone in the adrenal cortex. However, the expression of CYP11B1 and CYP21 have 
been reported in fetal testes of mice (Hu et al., 2007) and humans (Pezzi et al., 2003). In 
addition, the expression of CYP11B1 is found in rat Leydig cells (Wang et al., 2002).  
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Figure 1.3: Scematic overwiev of some of the enzymes and steroid hormones involved in the steroidogenic pathway of porcine Leydig cells (A). 
Pathway B presents part of corticosteroid synthesis in adrenal cortex. Refer to text for further details. 
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2. Materials and Methods 
For a detailed list of chemicals, solutions and media see appendix 8.1 and 8.2. For the 
preparation of discontinuous Percoll gradient see appendix 8.3. 
 
2.1 Chemicals 
The compounds 3-MeSO2-DDE (2-(3-methylsulfonyl-4-chlorophenyl)-2-(4-chlorophenyl)-
1,1-dichloroethene) and 3,3’-(bis)MeSO2-DDE (2,2’-bis(3-methylsulfonyl-4-chlorophenyl)-
1,1-dichloroethen) purity >99% were synthesized by Synthelec AB (Ideon, Lund, Sweden). 
o,p’-DDD (1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane) purity >99% was 
obtained from Sigma-Aldrich, Stockholm, Sweden.  
 
2.2 Isolation and culture of porcine Leydig cells  
The isolation and culture of porcine Leydig cells were obtained by the discontinuous Percoll 
gradient method (Bernier et al., 1983; Lejeune et al., 1998b), using a protocol authored by Dr. 
Steven Verhaegen, Norwegian School of Veterinary Science. By using differential 
centrifugation on discontinuous Percoll gradients the isolation of purified populations of 
Leydig cells is obtained. These primary Leydig cells maintain morphological and functional 
integrity and provide an in vitro model to investigate factors regulating testicular 
steroidogenesis. Due to time limits and the difficulties in predicting the amount of Leydig 
cells obtained at the different isolations, cell viability and hormone quantification is assessed 
on different cells. For cell viability assay two independent Leydig cell isolations/experiments 
were carried out, whereas three isolations were performed for hormone quantification and 
gene expression analysis. 
2.2.1 Procedure for Leydig cell isolation 
Testis from neonatal 8-12 days old Landrace piglets (Suidae, Sus scrofa) were obtained from 
routine castrations at the pig breeder farm Bøhnsdalen in Oslo. The castrations were 
performed by authorized veterinarians from the Norwegian School of Veterinary Science the 
same morning as the Leydig cells were isolated by standard surgical procedure for castration 
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of male piglets. Local anaesthesia was provided by injecting 0.5 ml 1% lidocain without 
adrenaline subcutaneously on both sides of scrotum and in each spermatic cord. The skin was 
washed and disinfected with 70% ethanol. After the surgical removal the testicles were 
immediately put in collection medium (see Appendix 8.2) in bottles and kept on ice (4°C). 
Immediately after the castration each piglet was administered 30 mg ketoprofen intramuscular 
for analgesia. Maximum time lapse from first gonad harvest until cell isolation started did not 
exceed 3 hours. The tissue dissociation for the neonatal boars was performed in cell culture 
lab in a laminar flow hood in sterile fashion. 500 ml glass flask (1 flask per 30 testicles) was 
preheated at 34°C. All testes were collected in petri dishes (VWR International AS, Oslo, 
Norway); about 15 in each dish, in collection medium (see Appendix 8.2). With sterile 
scissors and pinsets epididymis was removed and in a new petri dish each testis was 
decapsulated with flat tweezers and scissors and the parenchyma was scraped off. The 
decapsulated testes were collected in petri dishes with collection medium and the tissue were 
finely minced with scissors before pipetting into 50 ml Falcon tubes (BD Falcon, New Jersey, 
USA). The pellet was left to sediment and washed several times with collection medium to 
wash out blood until a clear supernatant was obtained. Dissociation buffer (see Appendix 8.2) 
was added to the 500 ml preheated bottles and the tissue suspension above was added and 
placed in a shaking water bath at 34°C. The extracellular matrix in the tissue was broken 
down during agitation. Digested tissue was collected after 45, 90 and 120 minutes (collection 
1, 2 and 3 respectively). After 45 minutes about half of the solution was decanted through a 
sterile metal filter into a clean beaker. The decanted volume was replaced with fresh 
collection medium and incubated further. The cell suspension was pipetted into 50 ml tubes 
and centrifuged at 1080 revolutions per minute (RPM) for 10 minutes. The supernatant was 
discarded and pellet resuspended in 50 ml collection medium to sediment for 5 minutes at unit 
gravity. Supernatant were transferred to new 50 ml tube and then sediment for 15 minutes 
before transferring to new 50 ml tubes and centrifuge at 1080 RPM for 10 minutes. The final 
pellet was resuspended in 5 ml collection medium and kept in fridge temporarily at 4°C 
(=collection 1). After about 90 minutes new half of the solution was decanted in the 
dissociation buffer and repeated all steps (=collection 2) and after 120 minutes again with the 
rest of the dissociation buffer solution (=collection 3). Then the three collected supernatants 
were pooled together and divided over the required number of Percoll gradients (5 ml sample 
to each gradient).  
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2.2.2 Purification of Leydig cells 
A discontinuous Percoll gradient was used to separate out the Leydig cells from the rest of the 
cells in the suspension made above. Discontinuous Percoll gradients were prepared as 
described in Appendix 8.3 the morning of the isolation. 5 ml of the pooled samples was 
applied carefully and slowly on top of each gradient. The gradients were centrifuged at 30 
minutes (4°C) at 2140 RPM. Then we aspirated the top layers with a pipette and with a new 
one recovered the Percoll 34% layer which should contain the Leydig cells (Figure 2.1). The 
collected Percoll fraction (5 ml) was diluted with collection medium at least two times and 
centrifuged at 1080 RPM for 20 minutes. The supernatant was discarded and pellet 
resuspended in collection medium (20 ml for about 60 testicles) and filtered through a 
polyester mesh into another 50 ml tube. The cells were counted in a Bürker haematocytometer 
(Superior, Marienfeld, Germany).  
 
 
Figure 2.1: The arrows indicate different solutions and final densities in a Percoll gradient. The 
Percoll 34% fraction contains the purified Leydig cells. 
 
2.2.3 Leydig cell plating 
For hormone readouts and RNA extraction the cells were plated out in 24-well cell culture 
plates (Falcon Primaria, VWR International AS, Oslo, Norway), while plated in 96-well 
plates (VWR, Norway) for the cell viability test. For the Leydig cell plating we diluted cells at 
concentration 10
6
 cells/ml with complete plating medium (see Appendix 8.2), the cell 
suspension was adjusted to 300 000 cells/ml. We added 1 ml of this suspension to each well 
of 24-well cell culture plates and 100 µl were plated out in each well in 96-well plates. Cells 
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were incubated for 72 hours prior to exposure, to allow the cells to form a monolayer, in a 
humidified incubator at 34°C and 5% CO2. 
 
2.4 3β-hydroxysteroid dehydrogenase staining method 
The purity of Leydig cells was assessed by histochemical 3β-hydroxysteroid dehydrogenase 
(3β-HSD) staining were the Leydig cells turn blue by reduction of tetrazolium blue dye 
(Huang et al., 2001; Levy et al., 1959). The 3β-HSD staining method was performed on two 
independent Leydig cell isolations to validate the method for isolation and purification of 
porcine Leydig cells. The purified Leydig cells were seeded out in 6-well plates (Falcon 
primaria, Becton Dickinson Labware, NJ USA) with complete plating medium and incubated 
for 72 hours at 37°C and 5% CO2. The complete plating medium was removed, the cells were 
washed with PBS 0.15 M pH 7.4 and 500 µl of trypsin was added to each well to let the cells 
detach. After two minutes trypsin was removed and 5 ml DMEM/F12 including 10% FCS 
was added to inactivate trypsin. The cells were transferred into a tube and centrifuged at 1500 
RPM for five minutes. The supernatant was discarded and pellet resuspended and incubated 
with 2 ml solution containing 0.2 mg/ml nitro blue tetrozolium, 0.12 mg/ml 5-androstane-3β-
ol-one and 1 mg/ml NAD
+
 in 0.05 M phosphate buffered saline (PBS), pH 7.4 at 37°C in a 
waterbath for 90 minutes. Blue formazan deposit sites of 3β-HSD activity developed and we 
could determine the abundance of Leydig cells by using a haematocytometer. 
 
2.5 In vitro exposure of cells 
After 72 hours incubation the Leydig cells were exposed to different concentrations of 3-
MeSO2-DDE, 3,3’-(bis)MeSO2-DDE and o,p’-DDD and stimulated with porcine LH. Before 
the exposure, the medium was refreshed with 1 ml complete plating medium per well in 24-
well plates and 100 µl per well in 96-well plates. Stock solutions of the compounds were 
prepared to 20 mM/ml in DMSO, divided into 50 µl aliquots and stored at -20°C until use. 
The cells were exposed to the different compounds at concentrations 0, 0.625, 1.25, 2.5, 5, 10 
and 20 µM finals solved in DMSO for 48 hours. The exposure concentrations used were 
decided from a study done by (Asp et al. 2009). Solvent control with 0.1% DMSO final 
concentration and medium blank with complete plating medium and LH only were included 
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(Figure 2.2). Immunochemical grade porcine LH was reconstituted in M199 modified Earle’s 
salts, without L-glutamine, sodium bicarbonate and phenol red (Sigma-Aldrich) at 25 ng/ml 
and stored at -80°C. This working stocks of 25 ng/ml were prepared by further diluting into 
complete DMEM/F12 and aliquots stored at -20°C. Aliquotes were thawed before use and not 
refrozen. To each well containing 1 ml of medium, 20 µl LH (25 ng/ml) was added, giving a 
final concentration of 0.5 ng/ml. For the cell viability assay, 2 µl LH was added to each well 
in 96-well plates. After 48 hours exposure to the test compounds in a humidified incubator at 
34°C and 5% CO2, the medium in 24-well plates was collected and stored at -80°C for 
hormone analysis. Plates with cells were stored at -80°C until harvest for RNA extraction. 
Each exposure was performed in triplicates and carried out as three independent Leydig cell 
isolations.  
In this same study another master student, Irene Sørvik, exposed Leydig cells without LH-
stimulation. 
Medium 
+LH 
Medium 
+LH 
Medium 
+LH 
0.1% DMSO 
+ LH 
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+ LH 
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Figure 2.2: Setup of exposure to the test compounds in a 24-well plate for hormone analysis 
and RNA extraction. 
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2.6 Cell viability assay  
Cell viability was estimated using the AlamarBlue Assay (Invitrogen) which incorporates an 
oxidation-reduction indicator that both fluoresces and changes color in response to chemical 
reduction of growth medium resulting from cell growth. The amount of fluorescence 
produced is proportional to the number of living cells and the more viable the cells are the 
more capable they are of transforming AlamarBlue fluorescent end products. After 48 hours 
exposure to the test compounds, the medium was replaced with 100 µl fresh complete plating 
medium which contained 10% AlamarBlue in each well of the 96-well plates to assess cell 
viability. The cells were incubated for three hours at 34°C and 5% CO2. Then a 100 µl sample 
was collected from each well into a transparent 96-well plate (Falcon, Franklin Lakes, NJ). 
The absorbance was measured at 570 nm and 600 nm wavelength in a spectrophotometer 
Victor
3
 1420 Multilabel plate reader (Perkin Elmer, Shelton, CT, USA). In addition, cells in 
the 24-well plates were treated with AlamarBlue for one hour. This is due to the original plan 
to incubate the cells in 24-well plates with AlamarBlue prior to hormone quantification, but 
one hour was not sufficient and 96-well plates was used for the cell viability test. For all cells 
to be treated equally, all 24-well plates were still treated for one hour with 10% AlamarBlue. 
Due to time limits, cells used in viability measurements were obtained from two different 
isolations, with three replicates/plates from the first isolation. Each replicate was performed in 
triplicates.  
 
2.7 Hormone analysis 
Cell medium levels of testosterone, estradiol and cortisol were measured using Coat-A-
Count® solid phase radioimmunoassay kits (RIA) (Siemens Medical Solutions Diagnostics, 
Los Angeles, CA, USA). Samples were measured in duplicate and standards were prepared in 
complete plating medium. Hormone levels were measured in a Wallac1470 Wizard (Perkin 
Elmer). The sensitivity of the testosterone assay was 0.1 ng/ml, corresponding to 95% binding 
of the labeled hormone. The standard curve ranged from 0-20 ng/ml. The interassay variation 
coefficients were 11.7% (2.4 ng/ml) and 14.1% (9.5 ng/ml) respectively. The sensitivity of the 
estradiol assay was 9 pg/ml and the standard curve ranged from 0-4000 pg/ml. Interassay 
variation coefficient were 6.7% (650.8 pg/ml) and 10.6% (1744.5 pg/ml) respectively. The 
cortisol assay sensitivity was 3 ng/ml and the standard curve range 0-500 ng/ml. The 
interassay variation coefficients were 9.8% (57.7 ng/ml) and 7.3% (210.2 ng/ml). 
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Progesterone concentrations were analyzed by a Spectria Progesterone RIA kit (Orion 
Diagnostica, Espoo, Finland). The standard curve ranged from 0-40 ng/ml and the assay 
sensitivity was 0.08 ng/ml. Interassay variation was 6.5% (3.87 ng/ml) and 6.1% (12.8 ng/ml) 
respectively.  
 
2.8 Gene expression analysis 
2.8.1 RNA isolation 
For the isolation of total RNA we used RNeasy Mini Kit (Qiagen Ltd, Crawley, UK) 
according to manufacturer’s protocol. Briefly, the frozen Leydig cells were lysed by adding 
200 µl RLT Lysis Buffer (Qiagen) directly to each well of the cultured plates. Cells were 
detached with pipette tips (1000 µl). Triplicates from each test concentration were pooled and 
transferred to a QIA shredder spin column (Qiagen), placed in a 2 ml collection tube, and 
centrifuged at 13000 RPM for 2 minutes. Samples were treated with 80 µl DNase I mixture 
(10 µl DNase and 70 µl RDD buffer) (Qiagen) for 10 minutes at room temperature. The 
samples were eluated in 55 µl RNase Free Water (Qiagen) and stored at -75°C until use. 5 µl 
of each samples was used for the RNA quality check and quantitative measurements, whereas 
50 µl was for the real-time RT-PCR.  
2.8.2 RNA quantity and quality  
RNA concentrations were measured using a NanoDrop ND-1000 Spectrophotometer (Thermo 
Scientific, Waltham, MA, USA) with 1 µl of the eluted sample. The RNA used in the gene 
expression analysis was isolated from control cells (DMSO) and the cells exposed to the next 
highest concentration of the test compounds, 10 µM. The mean RNA concentrations isolated 
and purified ranged between 70.3 – 171.4 ng/µl of RNA for DMSO samples and 72.2 – 148.8 
ng/µl of RNA for 10 µM samples. To examine the quality of purified RNA the Agilent 2100 
Bioanalyzer (Agilent Technologies Inc, California, USA) was used. Because of the instability 
of RNA, it is important to check the integrity and degradation of RNA before further analysis. 
The 2100 bioanalyzer expert software generated the RNA Integrity Number (RIN), ratios of 
ribosomal RNAs (28S/18S). RNA 6000 Nano LabChip
®
Kit (Agilent Technologies Inc) was 
used and the assay guide followed according to manufacturer’s instructions.  
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Results from the bioanalyzer indicated that all samples were of high quality and the mean 
28S:18S ribosomal RNA ratio was 1.8 and the mean RIN number was 9.1. The 
electropherogram showed no degradation or contamination of the RNA samples. An 
electropherogram with RNA of good quality from Leydig cell sample exposed to o,p’-DDD is 
presented in figure 2.3. 
 
 
Figure 2.3: An electropherogram of a RNA sample from exposed Leydig cells by using Agilent 
2100 Bioanalyzer. The integrity time (seconds) at x axis and the fluorescence (FU; 
Fluorescence Unit) is represented at y axis. The ribosomal RNA peaks, 18S and 28S, are 
indicated in the diagram. Gel-image of RNA products is shown to the right. 
 
2.8.3 Reference genes 
For the real-time RT-PCR assays 6 housekeeping genes (ACTB, PPIA, GAPDH, HPRT, 
PGK1, S18) were tested for suitability as reference genes. Using geNorm software analysis 
(PrimerDesign Ltd, Southampton, UK) the expression stability of these genes was tested. The 
two most stable genes, ACTB (β-actin) and PPIA (Cyclophilin A), had M-values at 0.27 and 
were selected as reference genes in this experiment (Figure 2.4).  
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Figure 2.4: Average expression stability values (M-value) of the 6 reference genes tested. ACTB 
and PPIA (cyclo A) was selected as reference genes (geNorm). 
The expression of reference genes, ACTB and PPIA, were reasonable stable in the different 
samples which indicates no effect of the test compounds on expression of the housekeeping 
genes used (Figure 2.5). 
 
 
Figure 2.5: Variation in CT-values (mean ± SE) for the reference genes ACTB and PPIA in the 
different samples from three experiments.   
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2.8.4 Primer design 
The genes selected for real-time RT-PCR analysis are involved in the steroidogenesis in 
Leydig cells and are summarized in Table 2.1. Porcine primers were already in house and had 
been designed prior to this study. Porcine primers for the reference genes were derived from 
(Duvigneau et al., 2005) (ACTB, HPRT, PPIA and GAPDH) or designed using PrimerExpress 
version 1.5 (Applied Biosystems, Foster City, CA, USA; PGK1 and S18). Primer sequences 
for the chosen genes; HMGR, CYP51, StAR, CYP11A1, CYP17A1, HSD3B, CYP19A1, 
HSD17B1, HSD17B4, CYP21, CYP11B1, CYB5, FTL, AKR1C4, NR5A1 and NR0B1 were also 
designed using PrimerExpress version 1.5 (Applied Biosystems). The primers were checked 
for specificity using nucleotide BLAST and primer BLAST 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi).  
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Table 2.1. Real-time RT-PCR primer sequences for the analyzed genes. ACTB and PPIA were used as reference genes.  
Gene abbrevation                          Gene name         Forward primer 5’- 3’ Reverese primer 5’- 3’ 
ACTB 
PPIA        
HMGR    
CYP51 
StAR 
CYP11A1 
CYP17A1 
HSD3B 
CYP19A1 
HSD17B1 
HSD17B4 
CYP21 
CYP11B1 
CYB5 
FTL 
AKR1C4 
NR5A1 
NR0B1 
Cytoskeletal beta actin 
peptidylprolyl isomerase A (cyclophilin A) 
3-hydroxy-3-methylglutaryl-coenzyme A reductase 
cytochrome P450, family 51, subfamily A, polypeptide 1 
Steroidogenic acute regulatory protein 
cytochrome P450 cholesterol side-chain cleavage 
cytochrome P450 17A1 
hydroxy-delta-5-steroid dehydrogenase 
cytochrome P450 19A1 
hydroxysteroid (17-beta) dehydrogenase 1 
hydroxysteroid (17-beta) dehydrogenase 4 
cytochrome P450, family 21, subfamily A, polypeptide 2  
cytochrome P450, family 11, subfamily B, polypeptide 1 
cytochrome b-5 
ferritin light polypeptide 
aldo-keto reductase family 1, member C4 
nuclear receptor subfamily 5, group A, member 1 
nuclear receptor subfamily 0, group B, member 1 
CTCGATCATGAAGTGCGACGT 
TGCTTTCACAGAATAATTCCAGGATTTA 
CTCGTGGCCAGCACCAATA 
TATGTGCCATTTGGAGCTGG 
AGAGCTTGTGGAGCGCATG 
CACCCCATCTCCGTGACC 
AGCCAAGACGAACGCAGAA 
GGAGCACTTTGAGGCCTGG 
AAAGCACCCCCAGGTTGAA 
TCGGGTCGCATATTGGTGA 
TTGCCATGAGAGTTGTGAGGAA 
CCATAGAGAACAGGGACCACCT 
GGAGGAAGCCAAGCAGAAAA 
TCAAAGATTGCCAAGCCTTCG 
TTCCTGGATGAGGAGGTGAAGC 
AAGTACAAGCCCGTCTGCAAC 
GCCAGGAGTTCGTCTGCCT 
GACCGTGCTCTTTAATCCGGA 
GTGATCTCCTTCTGCATCCTGTC 
GACTTGCCACCAGTGCCATTA 
GGAAAACGTACCACTGGAGTCAT 
CGAAGCATAGTGGACCAAATTG 
CATGGGTGATGACTGTGTCTTTTC 
GCATAGACGGCCACTTGTACC 
CCCCAAAGATGTCCGCAAC 
TTTTCAGCGCCTCCTTGTG 
CCACCACTTCGAGTTTTTGCA 
GCGCAGTAAACAGCGTTGAA 
GTCTTACAAGGGCTCCAAGGG 
TAGTCCAGCATGTCCCTCCAC 
CGCTGTAGTGCCACGGATG 
ACAACCAGTGCTGAGATGGCTG 
CTTTCGAAGAGGTACTCGCCCA 
TCCTTGGACTTGCAAAACTCC 
GTTCGCCTTCTCCTGAGCG 
TCCTGATGTGTTCGCTAAGGATC 
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2.8.5 Preparation of cDNA 
Prior to real-time RT-PCR experiment, the assay had already been optimized with respect to 
primer annealing temperatures. All products were checked on an agarose-ethidium gel to 
establish the presence of a single clear band of correct size per primer pair.  
cDNA was synthesized by reverse transcriptase (RT) using SuperScript® III Platinum Two-
Step qRT-PCR Kit with SYBR® Green (Invitrogen, Carlsbad, CA, USA) according to the 
manufactures protocol. Approximately 500 ng RNA was used in a final reaction volume of 20 
µl, containing 10 µl 2xRT Reaction mix, 2 µl RT Enzyme mix and 2 µl DEPC (Sigma-
Aldrich) water in a 96-well PCR plate. For each RNA sample a control with no added reverse 
transcriptase were included to check for genomic contamination. A negative control without 
template, in which 6 µl DEPC water was added instead of RNA, and positive control were 
included.  The reactions were set up as technical duplicates. After a quick spin down the 
reaction were performed in a Peltier Thermal Cycler-225 (MJ, Waltham, MA, USA) with the 
following program:  
 25°C for 10 minutes 
 42°C for 50 minutes 
 85°C for 5 minutes 
Plates were placed on ice; 1 µl of Rnase H (Invitrogen) were added to each well and 
incubated for 20 minutes at 37°C to remove any traces of RNA. The resulting cDNA was 
further diluted with DEPC water and stored at -20°C until use.  
 
2.8.6 Real-time RT-PCR 
Real-time RT-PCR was performed to check whether the selected genes were up-or down 
regulated in the exposed cells (10 µM) compared to controls (DMSO). A two-fold dilution 
serie with three concentrations of cDNA (1, 2 and 5 ng/µl cDNA) were performed to find the 
best cDNA concentration for the qRT-PCR using Superscript® III Platinum Two-step qRT-
PCR kit with SYBR Green (Invitrogen). For the present experiment a concentration of 1 ng/µl 
cDNA was used. Specific master mix for each gene was prepared with 5 ng cDNA, 200 nM 
primers, 12.5 µl Platinum SYBR Green supermix-UDG, 0.5 µl ROX dye (10x dilution) and 6 
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µl DEPC water in each well. The real-time RT-PCR reactions were set up as technical 
duplicates and included controls without RT. For each primer pair a negative control with no 
added template and a positive control were included. The q-PCR reactions were carried out 
using a DNA Engine Thermal Cycler with Chromo 4 Real-Time Detector (MJ Research) and 
its software Opticon Monitor 3 (Bio-Rad Laboratories, Hercules, CA, USA) with the 
following configuration: 
 50°C for 2 minutes (UDG incubation) 
 95°C for 2 minutes (enzyme activation) 
 95°C for 15 seconds (denaturation) followed by 62°C for 30 seconds (annealing) and 
72°C for 30 seconds (elongation). This step was repeated 40 cycles. Finally the 
melting curve from 65°C to 90°C read for 1 seconds every 0.3°C.  
A 10-fold dilution serie with five concentrations of cDNA was performed to check the 
amplification efficiency of each primer pair. We used a DMSO control sample and three 
exposed samples pooled together. The dilution series was 30, 3, 0.3, 0.03 and 0.003 ng/µl 
cDNA for the two samples. All primers had amplification efficiency between 1.8 and 1.99, 
which means that over 80% of the template in each PCR cycle was amplified during 
elongation.  
 
2.9 Statistical analysis 
Data were analyzed using Microsoft Excel 2003 and JMP 8 software (SAS Institute Inc 2007, 
Cary, NC, USA). Due to time limits, cytotoxicity was examined in two independent 
experiments/cell isolations, with three replicates from one isolation and one replicate from the 
second isolation (n=4) for each test compound. The effect of solvent control on cell viability 
was assessed by compare mean viability in cells incubated with 0.1% DMSO to medium 
blank (100%) with a paired two-tailed t-test (p<0.05). Since medium blank and DMSO are not 
affected by the exposure of test compounds, all three plates (one for each compound) within 
each replicate were combined (n=3). 
Differences in mean cell viability in exposed cells were compared to DMSO controls (100%) 
and assessed by one-way ANOVA and Dunnetts test. The mean viability in each sample was 
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from triplicates of each concentration from four replicates (n=4) with a p-value <0.05 
regarded as statistically significant. Cell viability and hormone data were tested for normality 
by the Shapiro-Wilk test. In case of non-normality in dependent variables a log or square root 
transformation was performed to make a better fit to the normal distribution. Log 
transformation of testosterone data and square root transformation of progesterone data from 
3-MeSO2-DDE and 3,3’-(bis)MeSO2-DDE exposed cells gave a satisfactory fit to the normal 
distribution and were used in the statistical analyses. Further, the variance was assessed for 
homogeneity by Levenes test. The parametric hormone data from cells exposed to 3-MeSO2-
DDE and 3,3’-(bis)MeSO2-DDE were analyzed by a two-way ANOVA with both exposure 
concentration and experimental run as independent variables. The differences in mean 
hormone levels in exposed and control cells were compared by Tukey HSD test to assess 
which concentrations were different from each other. P-values <0.05 were regarded as 
statistically significant. The hormone data from o,p’-DDD exposed cells was not normally 
distributed or homogenous in variance and was assessed by non-parametric Kruskal Wallis 
test. Due to the variation between the isolations, the mean hormone levels were assessed as 
percent of control (100%) and compared to control group with Bonferroni correction; 
p<0.0083 (0.05/6 doses) was used as statistically significant. Mean hormone concentrations 
was measured as technical duplicates, with triplicates of each exposure concentration in three 
independent experiments (n=9).   
Linear regression was used to assess if the response in hormone production followed a 
significant trend. Hormone concentrations, log or square root transformed concentrations 
were set as dependent variables and exposure dose entered as independent variable.  
From the real-time RT-PCR analysis the mean cycle threshold (CT) from three independent 
experiments for all tested genes were normalized to the mean of the two reference genes 
(ACTB, PPIA) in each sample. The 2
-ΔΔCt
-method was used to create fold changes in gene 
expression. The log2-transformed fold change values (ΔΔCt*(-1)) were used for statistical 
analysis by Student t-test with p-values <0.05 regarded as statistically significant.  
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3. Results 
3.1 Purity of Leydig cells (3β-HSD staining) 
After the isolation, plating and culturing of Leydig cells, a 3β-HSD staining was performed to 
assess the amount of Leydig cells in the cell preparation. The cell preparation was found to 
contain approximately 80% Leydig cells. 
 
3.2 Cytotoxicity of test compounds 
The cell viability was investigated by using the AlamarBlue assay. Since all test compounds 
were diluted in 0.1% DMSO the effect of 0.1% DMSO on Leydig cell viability was examined 
(Figure 3.1). Cells incubated with complete plating medium and LH only were used as 
controls. The results showed no significantly decreased cell viability from DMSO exposure 
compared to medium blank. 0.1% DMSO had no effect on Leydig cell viability.   
 
 
Figure 3.1: Effect of 48 hours 0.1% DMSO incubation on Leydig cell viability as percentage of 
control (medium blank; 100%). Shown are mean ± SE from three plates (n=3) in four replicates 
(1-4) from two independent experiments (1-3 within one experiment); two-tailed paired t-test; 
p<0.05. 
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Whereas Leydig cells exposed to 3,3’-(bis)MeSO2-DDE had no reduced viability (Figure 3.2 
B), cells exposed to both 3-MeSO2-DDE and o,p’-DDD had reduced viability compared to 
control cells (DMSO) (Figure 3.2 A and C). However, only the highest concentration (20 µM) 
of 3-MeSO2-DDE and o,p’-DDD caused significantly reduced viability compared to controls. 
Cell viability was reduced to 57 ± 8% and 19 ± 14% (mean ± SE) of control levels by 3-
MeSO2-DDE and o,p’-DDD, respectively. The viability was 91 ± 10% (mean ± SE) in cells 
exposed to 20 µM 3,3’-(bis)MeSO2-DDE. The exposure concentration (10 µM) used in gene 
expression analysis did not reduce cell viability compared to control levels, although cells 
exposed to o,p’-DDD had a non-significantly reduction in viability at 65 ± 16% (mean ± SE). 
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Figure 3.2: Viability of neonatal porcine Leydig cells exposed for 48 hours to A) 3-MeSO2-
DDE(red), B) 3,3’-(bis)MeSO2-DDE(blue) and C) o,p’-DDD(grey) as percent of solvent control 
(100%). Shown are median values, maximum and minimum after two independent experiments 
with four replicates (n=4). *significantly different from control group (Dunnetts test; p<0.05) 
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3.3 Hormone analysis 
Cell medium from LH-stimulated neonatal porcine Leydig cells exposed to 3-MeSO2-DDE, 
3,3’-(bis)MeSO2-DDE and o,p’-DDD was assessed for hormone production by RIA in three 
independent experiments. The triplicates within each experimental run were treated as 
biological replicates. The 48 hour exposure of the test compounds to LH-stimulated Leydig 
cells resulted in a concentration-dependent decrease in production of testosterone, estradiol 
and progesterone (Figure 3.3, 3.4 and 3.5). Cortisol was found to be secreted in concentrations 
close to the detection limit of the assay. Large variations were found between the experiments 
and the solvent control levels varied considerable. There were significantly differences 
between both exposure concentration and experimental runs for the hormone data exposed to 
3-MeSO2-DDE and 3,3’-(bis)MeSO2-DDE (two-way ANOVA , p<0.0001).  
3.3.1 Testosterone production 
The reduction in testosterone production by the compounds was most potent compared to 
reduction in estradiol and progesterone. There was a concentration-dependent decrease in 
testosterone production in exposed cells compared to controls (DMSO) induced by the 3-
MeSO2-DDE, 3,3’-(bis)MeSO2-DDE and o,p’-DDD (Figure 3.3).  
3-MeSO2-DDE reduced testosterone production in the Leydig cells compared to control levels 
at 38.5 ± 3.9 ng/ml (mean ± SE) (Figure 3.3 A). The testosterone production was significantly 
reduced at the four highest concentrations compared to unexposed cells (Table 3.1). The 
testosterone levels were decreased almost six-fold and 12-fold at 10 and 20 µM, respectively.  
In Leydig cells exposed to 3,3’-(bis)MeSO2-DDE there was a reduction in testosterone 
production compared to control levels at 53.5 ± 4.8 ng/ml (mean ± SE) (Figure 3.3 B). The 
production was significantly reduced at the four highest exposure concentrations (Table 3.1) 
and was reduced almost seven-fold (10 µM) and 13-fold (20 µM) at the two highest 
concentrations compared to control.  
o,p’-DDD exposure caused reduced testosterone production in Leydig cells compared to 
control levels at 27.2 ± 6.7 ng/ml (mean ± SE) (Figure 3.3 C). Testosterone levels were 
significantly decreased at the three highest concentrations compared to unexposed cells (Table 
3.1) and were decreased 14- and 23-fold at 10 and 20 µM, respectively. 
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Figure 3.3: Testosterone production in LH-stimulated Leydig cells from neonatal pigs after 48 
hour incubation with A) 3-MeSO2-DDE (red), B) 3,3’-(bis)MeSO2-DDE (blue) and C) o,p’-DDD 
(grey). Shown are minimum, first quartile, median, third quartile, and maximum values from 
three independent experiments performed in triplicates (n=9). Points more than 1.5 times the 
interquartile range above the third quartile/below the first quartile are defined as outliers and 
plotted individually(small circle). The statistics is presented in table 3.1.  
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Table 3.1: Results of the statistical analysis of testosterone data analyzed by Tukey HSD test 
(p<0.05) (3-MeSO2-DDE and 3,3’-(bis)MeSO2-DDE) with both experiment and exposure 
concentration as significantly variables (two-way ANOVA; p<0.0001). Non-parametric data 
(o,p’-DDD) analyzed by Kruskal-Wallis test with Bonferroni correction (p<0.0083). Each 
exposure concentration is compared to control group (DMSO), non-significant values; n.s.  
Compound 0.625 µM 1.25 µM 2.5 µM 5 µM 10 µM 20 µM 
3-MeSO2-DDE n.s n.s p<0.05 p<0.05 p<0.05 p<0.05 
3,3’-(bis)MeSO2-DDE n.s n.s p<0.05 p<0.05 p<0.05 p<0.05 
o,p’-DDD n.s n.s n.s P<0.0083 p<0.0083 p<0.0083 
 
 
3.3.2 Estradiol production 
The reduction in estradiol concentrations was less potent than what obtained in testosterone 
production. Estradiol production in exposed cells was reduced in a concentration-dependent 
manner by all three test compounds (Figure 3.4).  
Leydig cells exposed to 3-MeSO2-DDE had reduced estradiol production compared to control 
levels at 1205.7 ± 94.7 pg/ml (mean ± SE) (Figure 3.4 A). The estradiol production was 
significantly reduced at the two highest exposure concentrations (Table 3.2) with a 1.3-fold 
and 2.3-fold reduction from control at 10 and 20 µM, respectively.  
3,3’-(bis)MeSO2-DDE caused a decrease in estradiol production in Leydig cells compared to 
unexposed cells 2175.4 ± 137.7 pg/ml (mean ± SE) (Figure 3.4 B). The production was 
significantly reduced at concentrations 5, 10 and 20 µM compared to controls (Table 3.2) and 
was reduced by a 1.3- and two-fold at the two highest concentrations, respectively.  
o,p’-DDD exposed cells had reduced estradiol production compared to control levels at 
1096.7 ± 210.3 pg/ml (mean ± SE) (Figure 3.4 C). At exposure concentrations 10 and 20 µM, 
the estradiol levels were significantly reduced by 2.5- and 3.5-fold compared to controls, 
respectively (Table 2.3).  
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Figure 3.4: Estradiol production in LH-stimulated Leydig cells from neonatal pigs after 48 hour 
incubation with A) 3-MeSO2-DDE (red), B) 3,3’-(bis)MeSO2-DDE (blue) and C) o,p’-DDD (grey). 
Shown are minimum, first quartile, median, third quartile, and maximum values from three 
independent experiments performed in triplicates (n=9). Points more than 1.5 times the 
interquartile range above the third quartile is defined as outliers and plotted individually (small 
circle). The statistics are presented in table 3.2.  
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Table 3.2: Results of the statistical analysis of estradiol data analyzed by Tukey HSD test 
(p<0.05) (3-MeSO2-DDE and 3,3’-(bis)MeSO2-DDE) with both experiment and exposure 
concentration as significantly variables (two-way ANOVA; p<0.0001). Non-parametric data 
(o,p’-DDD) analyzed by Kruskal-Wallis test with Bonferroni correction (p<0.0083). Each 
exposure concentration is compared to control group (DMSO), non-significant values; n.s.  
Compound 0.625 µM 1.25 µM 2.5 µM 5 µM 10 µM 20 µM 
3-MeSO2-DDE n.s n.s n.s n.s p<0.05 p<0.05 
3,3’-(bis)MeSO2-DDE n.s n.s n.s p<0.05 p<0.05 p<0.05 
o,p’-DDD n.s n.s n.s n.s p<0.0083 p<0.0083 
 
3.3.3 Progesterone production 
The progesterone concentrations in the medium of LH-stimulated Leydig cells were very low.  
Some of the data measured were under the detection limit for the assay, but the changes in 
mean progesterone levels in relation to exposure concentrations of test compounds showed 
the same trends as for testosterone and estradiol (Figure 3.5).  
Leydig cells exposed to 3-MeSO2-DDE had reduced progesterone production compared to 
control levels at 1.19 ± 0.15 ng/ml (mean ± SE) (Figure 3.5 A). The production was 
significantly reduced at the three highest exposure concentrations (Table 3.3) and was 
decreased two- and almost three-fold by 10 and 20 µM, respectively.  
3,3’-(bis)MeSO2-DDE reduce progesterone production in Leydig cells compared to 
concentration in solvent control at 0.94 ± 0.09 ng/ml (mean ± SE) (Figure 3.5 B). At 
concentrations 2.5, 5, 10 and 20 µM the secretion of progesterone was significantly reduced 
compared to control levels (Table 3.3). Progesterone was reduced by 3,3’-(bis)MeSO2-DDE 
about five- and 17-fold at the two highest exposure concentrations.  
The progesterone secretion from cells exposed to o,p’-DDD was reduced compared to levels 
in unexposed cells at 1.01 ± 0.25 ng/ml (mean ± SE) (Figure 3.5 C). The production was 
significantly reduced in cells exposed to 5, 10 and 20 µM, respectively (Table 3.3) with 
production reduced by four-fold and nine-fold at the two highest doses, respectively.  
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Figure 3.5: Progesterone production in LH-stimulated Leydig cells from neonatal pigs after 48 
hour incubation with A) 3-MeSO2-DDE (red), B) 3,3’-(bis)MeSO2-DDE (blue) and C) o,p’-DDD 
(grey). Shown are minimum, first quartile, median, third quartile, and maximum values from 
three independent experiments performed in triplicates (n=9). Point more than 1.5 times the 
interquartile range above the third quartile is defined as outlier and plotted individually (small 
circle). The statistics are presented in table 3.3.  
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Table 3.3: Results of the statistical analysis of progesterone data analyzed by Tukey HSD test 
(p<0.05) (3-MeSO2-DDE and 3,3’-(bis)MeSO2-DDE) with both experiment and exposure 
concentration as significantly variables (two-way ANOVA; p<0.0001). Non-parametric data 
(o,p’-DDD) analyzed by Kruskal-Wallis test with Bonferroni correction (p<0.0083). Each 
exposure concentration is compared to control group (DMSO), non-significant values; n.s.  
Compound 0.625 µM 1.25 µM 2.5 µM 5 µM 10 µM 20 µM 
3-MeSO2-DDE n.s n.s n.s p<0.05 p<0.05 p<0.05 
3,3’-(bis)MeSO2-DDE n.s n.s p<0.05 p<0.05 p<0.05 p<0.05 
o,p’-DDD n.s n.s n.s p<0.0083 p<0.0083 p<0.0083 
 
3.3.4 Cortisol production 
The concentrations of cortisol were close to the detection limit of the assay and are not 
reported.  
 
3.4 Gene expression analysis 
Gene expression analysis was performed on the LH-stimulated Leydig cells with real-time 
RT-PCR. The gene expression analysis was done after 48 hour exposure to 3-MeSO2-DDE, 
3,3’(bis)-MeSO2-DDE and o,p’-DDD in three independent experiments. RNA was isolated, 
cDNA was synthesized and the expression of 16 genes involved in testicular steroidogenesis 
was measured using real-time RT-PCR. Relative quantification was done with solvent control 
(DMSO) as calibrator and exposure dose (10 µM) of the three compounds as test sample. The 
efficiency test of primers gave a satisfactory result of all primers tested. There was no effect 
of the test compounds on expression of the housekeeping genes used. Most of the genes 
examined were down-regulated in cells exposed to the test compounds compared to solvent 
control (Figure 3.6; p<0.05).  
In cells exposed to 3-MeSO2-DDE, the eight genes HMGR, StAR, CYP17A1, HSD3B, 
CYP11B1, CYP21, CYB5 and NR5A1 were significantly down-regulated compared to controls 
and fold change values are shown in Figure 3.6 A. The genes were slightly down-regulated 
between 1.6-3.4 times compared to control.  
Cells exposed to 3,3’-(bis)MeSO2-DDE had significantly down-regulation of the following 
seven genes; HMGR, CYP11A1, HSD3B, CYP11B1,CYB5, AKR1C4 and NR0B1 (Figure 3.6 
B). FTL was significantly up-regulated compared to controls. The genes were down-regulated 
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between 1.6-3.7 times, whereas FTL was up-regulated almost two times compared to controls. 
3,3’-(bis)MeSO2-DDE especially induced down-regulation of CYP11B1, almost 12 times 
compared to control. 
o,p’-DDD induced down-regulation most strongly of the test compounds. Eight genes 
involved in testicular steroidogenesis were down-regulated in cells following o,p’-DDD 
exposure compared to controls; CYP51, CYP17A1, HSD3B, CYP19A1, HSD17B4, CYB5, 
AKR1C4 and NR5A1 (Figure 3.6 C). Both CYP17A1 and CYP19A1 were down-regulated 
almost 19 times compared to control, while HSD3B levels decreased more than 60-fold. The 
other genes were down-regulated between 1.7-5.6 times compared to control. HMGR and 
CYP21 were not significantly down-regulated due to only two replicates.  
The exposure to 3-MeSO2-DDE, 3,3’(bis)-MeSO2-DDE and o,p’-DDD to porcine Leydig 
cells induced a general down-regulation of several genes involved in the testicular 
steroidogenesis, however, the compounds significantly altered slightly different genes. All 
three test compounds induced down-regulation of HSD3B and CYB5. A large variation in 
gene expression results of some of the genes was found between experiments.  
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Figure 3.6: Gene expression of 16 steroidogenic genes in LH-stimulated Leydig cells after 48 
hours incubation with 10 µM of A) 3-MeSO2-DDE (red), B) 3,3’-(bis)MeSO2-DDE (blue) and C) 
o,p’-DDD (grey) relative to DMSO control (line at 1). Shown are maximum, minimum and median 
fold change values from three independent experiments (n=3, exept n=2 for CYP21 and HMGR 
in panel C) on a logarithmic scale. Values above 1 indicate up-regulation, while values below 1 
represent down-regulation compared to control. * statistically different from control; Student t-
test; p<0.05. 
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4. Discussion  
To the best of our knowledge this is the first study investigating the steroidogenic effects of 
the three compounds 3-MeSO2-DDE, 3,3’(bis)-MeSO2-DDE, and o,p’-DDD in LH-stimulated 
neonatal porcine Leydig cells. All three compounds caused suppressive effects on neonatal 
Leydig cell steroidogenesis with concentration-dependent decreased hormone production and 
a general reduction in gene expression. The highest concentration (20 µM) of 3-MeSO2-DDE 
and o,p’-DDD was cytotoxic to the Leydig cells.  
The suppressive effects of DDT metabolites 3-MeSO2-DDE and o,p’-DDD on Leydig cell 
steroidogenesis in the present study might support the growing concern regarding persistent 
organic pollutants and their endocrine disruptive effect and potential role in negative trends in 
male reproductive health. The main DDT metabolite DDE which is widespread in the 
environment is converted to 3-MeSO2-DDE in mammals, and both 3-MeSO2-DDE and to less 
extent DDD metabolites of DDT are present in human tissues (Chu et al., 2003). However, 
o,p’-DDD is less common in the environment than the isomer p,p’-DDD (Falandysz et al., 
1999; Pazou et al., 2006; Ssebugere et al., 2010) thus, 3-MeSO2-DDE might be of most 
concern considering exposure to wildlife and humans. Another aspect to the present study was 
to contribute to further knowledge about steroidogenic effects of 3-MeSO2-DDE since it is 
suggested as alternative drug to o,p’-DDD in the treatment of ACC in humans.   
 
4.1 Purity of Leydig cells 
The purity of Leydig cells was assessed by histochemical 3β-hydroxysteroid dehydrogenase 
staining and the preparation in this study was found to contain approximately 80% Leydig 
cells. A purity of 80% is considered acceptable and in compliance with several studies (Brun 
et al., 1991; Geiger et al., 1999; Lejeune et al., 1998b; Li, 1991), although the content of 
Leydig cells might exceed 90% (Fombonne et al., 2003; Nakajima et al., 2003). Cells that 
were not identified as Leydig cells may represent Leydig cell precursors, Sertoli cells, 
macrophages, fibroblasts, endothelial cells and red blood cells. There might also be a 
possibility of a mixed cell type of adrenal-like and Leydig cells during development in the 
testis (Val et al., 2006). The determination of Leydig cell purity was not performed at the cell 
solutions used in the experiments for cell viability, hormone quantification and gene 
expression analysis, but the same Percoll gradient method were used every time. Some 
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variation in Leydig cell content might have been caused by variable quality of Percoll 
gradient layers and difficulties when sucking up the layer which contains the Leydig cells. 
 
4.2 Cytotoxicity of test compounds 
The possible cytotoxic effects of the compounds were assessed by the AlamarBlue assay. The 
effect of solvent control (0.1% DMSO) on the purified porcine Leydig cells was examined 
since the test compounds were diluted in 0.1% DMSO. The 0.1% DMSO did not have any 
effect on Leydig cell viability compared to control cells in the present study. DMSO is a well 
known solvent for chemicals and it was expected that 0.1% DMSO did not alter the cell 
viability (Da Violante et al., 2002). The variation observed between the replicates could be 
due to inexact pipetting, differences in duration of AlamarBlue incubation in each plate and 
variations in primary cell culture between the two cell isolations. 
Both 3-MeSO2-DDE and o,p’-DDD caused significantly decreased cell viability at the highest 
concentration (20 µM) compared to control cells, whereas 3,3’-(bis)MeSO2-DDE had no 
effect on Leydig cell viability. o,p’-DDD seemed to be the most potent compound, with two 
of the experiments causing zero viability at 20 µM and a non-significantly reduction at 10 
µM. Due to variation in primary cultures, several experimental runs should be included to 
evaluate the compounds effect on cell viability. Nevertheless, in all replicates there was 
decreased cell viability at the highest concentration of 3-MeSO2-DDE and o,p’-DDD. 
Similar to the present study, both 3-MeSO2-DDE and o,p’-DDD decreased viability in human 
adrenocortical carcinoma cell line (H295R) in a concentration-dependent manner, although 3-
MeSO2-DDE was the most potent drug (Asp et al., 2010). Further, 3-MeSO2-DDE caused 
concentration-dependent cytotoxicity in forskolin-stimulated mice adrenocortical cell line (Y-
1) at concentrations equal to what is used in the present study,  whereas o,p’-DDD only 
caused a slight, but non-significantly decrease in cell viability (Asp et al., 2009). This is in 
contrast to the present study were o,p’-DDD seems to induce cytotoxicity more potent than 3-
MeSO2-DDE. The differences in potency between the compounds might be due to species 
differences (Asp et al., 2010; Brandt et al., 1992) and different types of cells. The cytotoxicity 
of 3-MeSO2-DDE is CYP11B1-dependent in mice (Asp et al., 2009), but as porcine Leydig 
cells are not reported to have CYP11B1 enzyme activity, the cytotoxicity in the present study 
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might involve other mechanisms. In addition, the cytotoxicity following 3-MeSO2-DDE 
exposure in H295R cells was not counteracted by the CYP11B1-inhibitor etomidate, 
indicating that other steroidogenic enzymes might be involved in the toxic effect (Asp et al., 
2010). The drug-induced cell death of o,p’-DDD in the adrenal cortex occurs after CYP-
catalyzed bioactivation and might involve several steroidogenic enzymes, including 
CYP11B1 and CYP11A1 (Hart and Straw, 1971; Hart et al., 1971). The exact enzyme(s) 
responsible for the bioactivation is not known (Ahlman et al., 2001; Stigliano et al., 2008). 
Therefore, both 3-MeSO2-DDE and o,p’-DDD might interfere with several steroidogenic 
enzymes that can activate the compounds to reactive intermediates and hence cause 
cytotoxicity in the porcine Leydig cells, as suggested in adrenal cells. However, this is only 
one possible mechanism.  
Exposure to 3,3’-(bis)MeSO2-DDE did not reduce the cell viability in the neonatal porcine 
Leydig cells. A previous study demonstrated cytotoxicity following 3,3’-(bis)MeSO2-DDE 
exposure in mice adrenal cells, although less potent than 3-MeSO2-DDE (Asp et al., 2009). 
Since the methylsulfonyl moiety seems to be important for CYP11B1-dependent toxic effects 
of 3-MeSO2-DDE in adrenal cells (Hermansson et al., 2007; Lund et al., 1988) the extra 
methylsulfonyl group might then explain why 3,3’-(bis)MeSO2-DDE is nontoxic in the 
present study. If interference with enzymes may cause cytotoxicity, it might be that structure-
specific bioactivation of the compounds by other enzymes than CYP11B1 could explain the 
difference in cytotoxic effects of the compounds reported here.   
 In summary, o,p’-DDD and to a less extent 3-MeSO2-DDE caused cytotoxicity at 20 µM, 
whereas 3,3’-(bis)MeSO2-DDE exposure had no effect on Leydig cell viability. The different 
effect on cell viability by the compounds might be structure-dependent. 
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4.3 Effect of test compounds on LH-stimulated Leydig cell 
steroidogenesis 
The present study examined the steroidogenic effects of two DDT metabolites and one 
synthetic DDE analogue in primary cultures of LH-stimulated neonatal porcine Leydig cells. 
The three test compounds 3-MeSO2-DDE, 3,3’-(bis)MeSO2-DDE, and o,p’-DDD caused a 
reduction in testosterone, estradiol and progesterone secretion by the Leydig cells in a 
concentration-dependent manner. In addition, the test compounds induced down-regulation of 
several genes involved in Leydig cell steroidogenesis. The decreased hormone production was 
observed at concentrations lower than the cytotoxic concentration (20 µM) of 3-MeSO2-DDE 
and o,p’-DDD, indicating that the decrease in hormone production was not due to 
cytotoxicity. In addition, 3,3’-(bis)MeSO2-DDE exposure reduced hormone production in 
Leydig cells without affecting cell viability. However, since the cytotoxicity assay was 
performed on cells other than those used for hormone quantification, and obtained from only 
two independent experiments, reduced hormone production due to less viable cells cannot be 
excluded. The large variations in hormone and gene expression results between experiments 
may reflect that primary cultures of Leydig cells were used in the present study. Primary 
cultures are different than established cell lines in reflecting the individuals the cells are 
obtained from and hence there will be some variation. Sources of variation could include 
variation in Percoll gradient quality, Leydig cell content and differences in number and age 
(8-12 days) of male piglets from the litters between the cell isolations.  
 
4.3.1 Effect on hormone production in LH-stimulated Leydig cells 
The cells were stimulated with the physiological hormone stimulator LH which maintain the 
steroidogenic activity and increase the hormone secretion in primary porcine Leydig cells 
(Bernier et al., 1983; Lejeune et al., 1998b; Mather et al., 1981).  
The LH stimulated cells were then exposed to 3-MeSO2-DDE, 3,3’-(bis)MeSO2-DDE and 
o,p’-DDD, which led to a similar pattern of reduced testosterone, estradiol and progesterone 
production for all three compounds. A reduction in hormone production by these compounds 
has previously been demonstrated in adrenal cells and linked to interference with 
steroidogenic enzymes at the protein level (Asp et al., 2009). The compounds might have 
acted in a similar manner in the Leydig cells from the present study and caused the observed 
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decrease in hormone production. Reduced activity of steroidogenic enzymes is indeed related 
to decreased hormone production in Leydig cells (Akingbemi et al., 2000; Ohno and 
Nakajima, 2005). For instance, both testosterone and progesterone are reduced in porcine 
Leydig cells by the specific CYP-inhibitors ketoconazole and aminoglutethimide by inhibition 
of CYP11A1 (Brun et al., 1991). However, the possible interaction between enzyme activity 
and the compounds was not investigated in the present study.  
After exposure to 3-MeSO2-DDE, 3,3’-(bis)MeSO2-DDE and o,p’-DDD, testosterone 
production seemed to be more reduced than estradiol and progesterone production. 
Testosterone concentrations was still measured in levels elevated compared to estradiol and 
progesterone, and since testosterone is the main steroid hormone synthesized by Leydig cells, 
it may be most affected by suppression of Leydig cell steroidogenesis. The low amounts of 
progesterone might reflect its role as an intermediary compound in the biosynthesis of steroids 
in the testes (Raeside et al., 2006; Ruokonen and Vihko, 1974). In addition, the Δ5 pathway 
(Figure 1.3) of androgen and estrogen synthesis predominates in pigs, this pathway converts 
pregnenolone to testosterone via 17α-hydroxypregnenolone and not via progesterone 
(Ruokonen and Vihko, 1974). However, since some progesterone levels were obtained, the 
steroid synthesis through Δ4 pathway to progesterone might also occur (Conley and Bird, 
1997). As progesterone was reduced in a similar way as testosterone and estradiol, it might 
suggest that the test compounds affect the steroidogenesis cascade upstream.  
In the present study, cortisol levels were not detected by the assay, either from unexposed or 
exposed cells, indicating no production of cortisol by the Leydig cells. Cortisol participate in 
regulating sperm output in mature boars (Wagner Claus 2004) and corticosteroids might 
inhibit testosterone production by cultured porcine Leydig cells (Bernier et al., 1984). The 
activity of CYP11B1, the enzyme synthesizing cortisol, is not previously reported in porcine 
Leydig cells, although found in rat Leydig cells (Wang et al., 2002).  
3-MeSO2-DDE exposure caused a reduction in testosterone, estradiol and progesterone 
secretion, with only the highest concentration being cytotoxic. 3-MeSO2-DDE has previously 
been demonstrated to inhibit corticosteroid production in adrenal cells due to interaction with 
the steroidogenic enzyme CYP11B1 at the protein level (Asp et al., 2009; Johansson et al., 
1998; Johansson et al., 2002; Lindhe et al., 2002). Since the production of testosterone, 
estradiol and progesterone does not involve CYP11B1 (Figure 1.3), the reduction in hormone 
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production following 3-MeSO2-DDE exposure in the present study is likely to involve other 
steroidogenic enzyme(s) or mechanisms not previously described to be affected by 3-MeSO2-
DDE.  
Reduction of testosterone, estradiol and progesterone production was induced by 3,3’-
(bis)MeSO2-DDE exposure. In adrenal cells, the reduction in corticosteroid production by 
3,3’-(bis)MeSO2-DDE is less potent compared to 3-MeSO2-DDE and o,p’-DDD (Asp et al., 
2009). The bioactivation of 3-MeSO2-DDE by CYP11B1 is reported to be structure-specific 
(Hermansson et al., 2007; Lund et al., 1988), hence the extra methylsulfonyl group of 3,3’-
(bis)MeSO2-DDE could  affect the affinity to other steroidogenic enzymes and cause different 
steroidogenic effects by the compounds. However, reduction in hormone production did not 
seemed to be less potent by 3,3’-(bis)MeSO2-DDE exposure, at least for testosterone and 
estradiol.  
All three hormones decreased following o,p’-DDD exposure. The reduced steroid hormone 
secretions at the highest concentration could be caused by reduced cell viability. o,p’-DDD 
has previously been reported to reduce testosterone and progesterone synthesis in H295R 
cells, although the mechanism at which o,p’-DDD inhibit adrenal steroidogenesis is still 
unknown (Stigliano et al., 2008). Several steroidogenic enzymes might be involved in the 
reduction of hormone production by o,p’-DDD, and it is previously reported to inhibit 
CYP11A1 (Hart et al., 1973; Hart et al., 1971) which could inhibit steroid hormone 
production in Leydig cells. 
In summary, all three compounds decreased LH-stimulated hormone production in cultured 
porcine Leydig cells in a concentration-dependent manner. The reduction in progesterone as 
well as testosterone and estradiol might indicate that the compounds affect the steroidogenesis 
upstream.  
4.3.2 Effect on gene expression in LH-stimulated Leydig cells 
Expression of 16 genes involved in Leydig cell steroidogenesis were investigated after 
exposure to 10 µM 3-MeSO2-DDE, 3,3’-(bis)MeSO2-DDE and o,p’-DDD. The overall trend 
in gene expression suggests that all three compounds induce down-regulation of several genes 
relative to expression in control cells, suggesting that the compounds interfere at mRNA level. 
The suppressive trend in expression of some genes might be an explanation to the observed 
reduced hormone levels following exposure to the compounds at the same concentration.  
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The results indicate that the three compounds reduce mRNA levels of slightly different 
steroidogenic genes. o,p’-DDD seems to reduce the gene expression levels more potently 
compared to 3-MeSO2-DDE and 3,3’-(bis)MeSO2-DDE. Although not significantly cytotoxic 
at 10 µM, the reduced cell viability by o,p’-DDD at this concentration cannot be excluded.  
The three compounds each significantly altered expression of eight genes, all down-regulated 
except for one. 3-MeSO2-DDE exposure significantly induced down-regulation of HMGR, 
StAR, CYP17A1, HSD3B, CYP11B1, CYP21, CYB5 and NR5A1, whereas 3,3’-(bis)MeSO2-
DDE exposure significantly reduced expression of HMGR, CYP11A1, HSD3B, 
CYP11B1,CYB5, AKR1C4 and NR0B1. In addition, 3,3’-(bis)MeSO2-DDE caused an 
significant up-regulation of FTL. o,p’-DDD exposure significantly induced CYP51, 
CYP17A1, HSD3B, CYP19A1, HSD17B4, CYB5, AKR1C4 and NR5A1(Figure 3.6). The 
overall trend suggests the compounds induce a suppression of gene expression along the 
steroidogenic pathway. 
Expression of genes involved in steroidogenesis 
The genes CYP51 and HMGR encode enzymes involved in cholesterol biosynthesis (Debeljak 
et al., 2003; Rodwell et al., 1976) and steroidogenesis is critically dependent on cholesterol as 
a substrate. The inhibition of CYP51 has been reported to reduce serum testosterone levels in 
humans (Miettinen, 1988). Several of the genes down-regulated in the present study are 
encoding enzymes involved in Leydig cell steroidogenesis (Figure 1.3) and reduced activity 
of these enzymes might decrease hormone production by Leydig cells (Brun et al., 1991; 
Nakajima et al., 2005; Ohno and Nakajima, 2005; Shi et al., 2010; Walsh and Stocco, 2000). 
The StAR protein mediates the first important step in transfer of cholesterol from the outer to 
the inner mitochondrial membrane (Stocco, 2001) hence reduced activity of StAR might 
inhibit steroidogenesis. The reduction of StAR mRNA might account for decrease in StAR 
protein and inhibition of progesterone synthesis in mouse Leydig cells exposed to lindane 
(Walsh and Stocco, 2000). The next rate-limiting step in steroidogenesis is the conversion of 
cholesterol to pregnenolone by CYP11A1 and inhibition of CYP11A1 in porcine Leydig cells 
has been demonstrated to suppress progesterone and testosterone synthesis (Brun et al., 1991). 
Further, several enzymes are involved in the Δ4 and Δ5 pathway for the synthesis of 
androgens and estrogens, including CYP17A1 and 3βHSD (Conley and Bird, 1997). Decrease 
in CYP17A1 expression has previously been linked to reduced testosterone secretion in 
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neonatal porcine Leydig cells (Nakajima et al., 2005). CYB5 interacts with CYP17A1 and are 
important for the 17,20 lyase activity in the androgen synthesis (Nakajin et al., 1985). The 
CYB5 protein is widely involved in biological processes, being a component of electron 
transfer chains in several pathways, (Bonfils et al., 1981; Grindflek et al., 2010; Schenkman 
and Jansson, 2003). Thus, a decrease in expression of these genes might explain the reduction 
in steroid hormone production observed in this study. Even though the compounds might 
reduce expression of slightly different genes, all three compounds reduce mRNA levels of 
genes that might be associated with reduced hormone production, for example the expression 
of HSD3B and CYB5 were significantly reduced by all three compounds. 
The reduced estradiol production following o,p’-DDD exposure might have been caused by 
the decreased expression of CYP19A1, which codes for the enzyme aromatase that converts 
testosterone to estradiol (Conley et al., 1996). Another enzyme involved in estradiol 
production encoded by HSD17B4 and is capable of converting estradiol to estrone (Adamski 
et al., 1995). Reduction in mRNA levels of this gene could be associated with reduced 
formation of estrone and can therefore not explain the reduction in estradiol levels measured 
in the present study. The level of estrone production was not measured and the relative 
amounts of estrone vs estradiol cannot be discussed. However, there were no significantly 
alterations in expression levels of HSD17B1, the enzyme converting estrone to estradiol.  
The last step in testosterone synthesis is the convertion of androstenedione to testosterone 
catalyzed by another type of hydroxysteroid dehydrogenase is HSD17B3 (Andersson et al., 
1996; Luu-The, 2001). However, expression of HSD17B3 was not included in the present 
study. Another possible mechanism by which measured steroid levels would be low is 
through the action of AKR1C4. AKR1C4 is involved in converting androgens and estrogens 
to their inactive metabolites which might reduce the levels of circulating steroid hormones 
and the steroids might be substrates for conjugation reactions (Penning et al., 2000). However, 
if the activity of AKRIC4 was responsible for reduction in hormone levels, an increase in 
AKR1C4 expression would be expected rather than the reduction observed in the present 
study.  
The only gene significantly up-regulated in the study was FTL, following 3,3’-(bis)MeSO2-
DDE exposure. FTL encodes the ferritin light polypeptide which is part of ferritin, an 
important protein for many cellular functions. Increased mRNA levels of FTL could possibly 
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increase ferritin which in turn could increase the iron storage capacity of the cell (Hentze and 
Kuhn, 1996). This might be one possible mechanism for the sustained cell viability seen in 
3,3’-(bis)MeSO2-DDE exposed cells.  
Expression of transcription factors 
Gene expression levels of two transcription factors involved in steroidogenesis was 
investigated, NR5A1 and NR0B1. The steroidogenic transcription factor NR5A1 (SF-1) is an 
important transcriptional activator which increase mRNA levels and induce transcription of 
CYP11A1, HSD3B, CYP19A1, CYP17A1, CYP21 and StAR (Sadovsky and Dorn, 2000; 
Sugawara et al., 1996). Hence, reduced mRNA levels of NR5A1 could result in down-
regulation of these genes, and the subsequent reduction in hormone secretion observed in the 
present study. Both 3-MeSO2-DDE and o,p’-DDD did reduce mRNA levels of NR5A1 which 
might have affected the other genes; HSD3B, CYP17A1(both), StAR, CYP21(3-MeSO2-DDE) 
and CYP19A1(o,p’-DDD). The other transcription factor investigated, NR0B1 (DAX-1), has 
previously been shown to inhibit expression of StAR, HSD3B and CYP17A1 (Lalli et al., 
1998), which are genes with suppressed expression in the present study. After 3,3’-
(bis)MeSO2-DDE exposure, the expression of NR0B1 was down-regulated, hence the 
observed down-regulation of HSD3B expression cannot be explained by the activity of this 
transcription factor.  
Expression of CYP21 and CYP11B1 
Gene expression levels of the steroidogenic enzymes CYP11B1 and CYP21 were investigated 
as the compounds are adrenal toxicants. Neither CYP11B1 nor CYP21 are involved in 
androgen and estrogen synthesis, but synthesize cortisol (Figure 1.3). Nevertheless, the 
expression of both CYP11B1 and CYP21 observed in this study support the suggestion that 
adrenal and Leydig cells might originate from a common precursor (Hatano et al. 1996, Val 
2006). The expression of CYP11B1 and CYP21 are previously reported in fetal testis of mice 
(Hu et al., 2007) and humans (Pezzi et al., 2003), and might be expressed by a subpopulation 
of fetal Leydig cells or adrenal-like cells in the testes (Hu et al., 2007; Val et al., 2006). The 
obtained Leydig cell purity of 80% does not exclude that other cells than Leydig cells might 
express CYP11B1 and CYP21, as proposed in mice. The mRNA levels of CYP11B1 and 
CYP21 were reduced after 3-MeSO2-DDE and 3,3’-(bis)MeSO2-DDE exposure, but as no 
detectable cortisol was measured in the medium either from control cells or exposed cells, 
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CYP11B1 and CYP21 enzyme activity might not be present. Since corticosteroids might 
inhibit Leydig cell function and suppress testosterone secretion, inhibition of CYP11B1 
translation may prevent high levels of corticosteroid production by the testes, and hence 
prevent decreased testosterone secretion (Hu et al., 2007). Nonetheless, expression of 
CYP11B1 and CYP21 is found in the porcine testes in the present study in accordance to 
previous findings in other species (Hu et al., 2007; Pezzi et al., 2003; Wang et al., 2002).  
Effect of compounds on LH-induced cAMP-pathway 
The general suppression of mRNA levels as well as hormone production by the compounds 
might be linked to interference with LH function. The Leydig cells were stimulated with LH 
which increases the mRNA level of several enzymes in the testicular steroidogenesis (Clark et 
al., 1996; Clark et al., 1994; Debeljak et al., 2003; Sugawara et al., 1996) and boost 
cholesterol transfer to the inner mitochondrial membrane via the cAMP - protein signaling 
pathway (Dufau, 1998). Since binding of LH to its receptor will increase cAMP levels and 
steroidogenic activity in the Leydig cells, reduced cAMP-synthesis might therefore decrease 
steroid hormone secretion and expression of steroidogenic enzymes (Laurich et al., 2002; Li, 
1991; Penhoat et al., 1988; Ronco et al., 2001). Testosterone production and CYP17A1 
mRNA levels induced by LH/hCG-stimulation was reduced after exposure to tributyltin 
chloride (TBT) in neonatal porcine Leydig cells by reduced intracellular cAMP levels 
(Nakajima et al., 2005). The mother compound DDE might inhibit the generation of cAMP 
(Whitehead and Rice, 2006). Reduced cAMP levels might therefore be one possible 
mechanism for decreased steroidogenic activity causing suppression in hormone production 
and gene expression.  
In summary, both hormone quantification and gene expression analysis indicated a suppressed 
effect on Leydig cell steroidogenesis induced by the test compounds. The reduction in mRNA 
levels of some genes might be associated with reduced hormone production, although the 
compounds suppressed expression of slightly different genes. Gene expression was reduced 
slightly more potent by o,p’-DDD than 3-MeSO2-DDE and 3,3’-(bis)MeSO2-DDE.  
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4.4 LH-stimulated versus basal steroidogenesis 
As part of the same project and carried out parallel with the present study, exposure of 3-
MeSO2-DDE, 3,3’-(bis)MeSO2-DDE and o,p’-DDD was investigated on basal steroidogenesis 
by another master student, Irene Sørvik. The findings suggest different response in basal 
steroidogenesis compared to what obtained in LH-stimulated Leydig cells in this study. First, 
the basal steroid hormone concentrations and mRNA levels were lower compared to LH-
stimulated levels, confirming the stimulatory effect of LH. The study (unpublished) report a 
slight stimulatory trend of basal steroidogenesis, with induced concentrations of testosterone, 
and to a less extent estradiol, after exposure to the test compounds (Sørvik, 2010) which is 
opposite of the suppression observed in the present study. A similar response is reported in 
cultured rat Leydig cells, with inhibition of LH-mediated testosterone production, but 
stimulation of basal steroidogenesis (Midzak et al., 2007). They suggested that inhibition of 
the mitochondrial electron transport chain might block LH-stimulated testosterone production 
through suppression of several steps of the steroidogenic pathway, but increase the basal 
steroidogenesis through a calcium-mediated mechanism. A similar explanation could be 
involved in the present study. The steroidogenic stimulation by LH involves increased 
cholesterol transfer and mitochondria play a central role as transfer of cholesterol to the inner 
mitochondrial membrane is the rate-limiting step in the synthesis of steroid hormones. 
Disruption of mitochondrial function might therefore have a suppressive effect on the Leydig 
cell steroidogenesis, also reported in mouse Leydig cells (Allen et al., 2006). The inhibition of 
the mitochondrial electron transport chain caused reduction in testosterone production in the 
LH-stimulated rat Leydig cells and was associated with reduced ability of the
 
cells to produce 
cAMP and with reduced steroidogenic enzyme activities. Another effect of electron transport 
chain inhibition is increased intracellular calcium levels (Duchen et al., 1990; Midzak et al., 
2007). Increase in calcium concentrations has been reported in parallel with increased 
testosterone synthesis and the calcium-dependent increase of testosterone might be 
independent on cAMP (Sullivan and Cooke, 1986). Inhibition of electron transport chain 
might therefore be involved in both suppression of LH-stimulated and increase of basal 
Leydig cell steroidogenesis. The suppressed effect of 3-MeSO2-DDE, 3,3’-(bis)MeSO2-DDE 
and o,p’-DDD on LH-stimulated porcine Leydig cell steroidogenesis might involve disruption 
of mitochondrial function and reduction in cAMP levels, as one possible mechanism.  
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4.5 Reasons for concern? 
The present study report that 3-MeSO2-DDE, 3,3’-(bis)MeSO2-DDE, and o,p’-DDD 
suppressed the steroidogenesis in neonatal porcine Leydig cells indicating a disruptive effect 
on testicular steroidogenesis. Reduction in testosterone production might be of concern as 
testosterone is important for male sex development and testis function (Gnessi et al., 1997). 
There is an increased concern regarding endocrine disruptors and their effect on male fertility 
(Eertmans et al. 2003) and the mother compounds DDT and DDE are already known 
endocrine disruptors that might impair reproduction in wildlife (Kelce et al., 1995; Sharpe, 
1995; Sohoni and Sumpter, 1998; Whitehead and Rice, 2006). The suppressive effects and 
endocrine disruption on Leydig cell steroidogenesis by the DDT metabolites 3-MeSO2-DDE 
and o,p’-DDD might be of concern considering negative impact on mammalian reproduction. 
The compounds reduced hormone production with increasing concentrations and caused 
cytotoxicity at the highest concentration. When revealing endocrine disrupting effects of 
compounds using cell systems, it is important to keep in mind whether the in vitro effects and 
the doses used are relevant and applicable to in vivo exposure. As DDT metabolites are 
persistent and lipophilic, the test compounds are highly fat soluble and thus might concentrate 
to a higher degree in adipose tissue, breast milk (Kanja et al., 1992) and reproductive tissues 
such as testes (Szymczynski and Waliszewski, 1983). Both 3-MeSO2-DDE and o,p’-DDD 
derives from DDT metabolites that are widespread and persistent in the environment. 3-
MeSO2-DDE and o,p’-DDD accumulates in fat tissues of minipigs, but 3-MeSO2-DDE is 
more slowly eliminated (Hermansson et al., 2008). 3-MeSO2-DDE is present in tissues of 
mammals (Bergman et al., 1994; Letcher et al., 1995), humans and in breast milk (Chu et al., 
2003; Noren et al., 1996; Noren and Meironyte, 2000). In areas where DDT is still in use or 
banned at a later date, the levels of DDE in human breast milk are higher (Azeredo et al., 
2008). The suppressive effects on Leydig cell steroidogenesis during neonatal development 
might be of concern considering exposure of 3-MeSO2-DDE through breast milk to suckling 
newborns, as reported in mice (Jonsson et al., 1992) and pigs (Kismul, 2009). Therefore, 
human risk assessment of 3-MeSO2-DDE is suggested to be focused on breast-fed infants. 
This might be considered as 3-MeSO2-DDE is suggested as a potential drug for ACC, 
exposure during development might cause disruption of Leydig cell steroidogenesis. o,p’-
DDD is also present in the environment, although in less concentrations than the isomer p,p’-
DDD (Falandysz et al., 1999; Ssebugere et al., 2010). In addition to the known toxic effects of 
o,p’-DDD in adrenal cortex it might also disrupt Leydig cell steroidogenesis as reported in the 
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present study. Human malignant Leydig cell tumor has been reported to respond well to o,p’-
DDD treatment (van der Hem et al., 1992) and o,p’-DDD is reported to have estrogen activity 
characteristics (Tyler et al., 1998). 3,3’-(bis)MeSO2-DDE is a synthetic DDE analogue and 
hence is not of concern regarding exposure from the environmental, but it has been 
investigated as a part of the improvement of ACC therapy in humans. Toxicants capable of 
affecting Leydig cell function may cause spermatogenic damage resulting from androgen 
deficiency and as Leydig cells play a crucial role in testicular functions they might be target 
of testicular toxicity in vivo (Steinberger and Klinefelter, 1993). Even though experimental 
concentrations at which endocrine effects are observed are usually above those being 
measured in the body, the lack of information about mechanisms and metabolism into 
potentially more active compounds cannot be ignored (Whitehead and Rice, 2006). Although 
not possible to directly extrapolate to in vivo effects, in vitro studies might give an indication 
of possible endocrine disrupting effects and the mechanisms causing them. Porcine Leydig 
cells in culture is a good model for evaluating steroidogenic effects of compounds (Brun et 
al., 1991) and the in vitro results obtained in the present study indicate an endocrine 
disrupting effect on Leydig cell steroidogenesis. 
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5. Conclusions  
To the best of our knowledge  the present study is the first to investigate possible endocrine 
disrupting effects of 3-MeSO2-DDE, 3,3’-(bis)MeSO2-DDE and o,p’-DDD on LH-stimulated 
neonatal porcine Leydig cells. The results suggest a suppressive effect of the test compounds 
on LH-stimulated Leydig cell steroidogenesis, but with large variation in studied endpoints 
between experiments.  
Both 3-MeSO2-DDE and o,p’-DDD reduced Leydig cell viability with cytotoxic effect at the 
highest concentration (20 µM). o,p’-DDD was the most potent compound, whereas 3,3’-
(bis)MeSO2-DDE did not have any effect on cell viability in the present study. This might 
indicate that the cytotoxic effects are structure-dependent and that the extra methylsulfonyl 
group makes 3,3’-(bis)MeSO2-DDE less toxic. 
3-MeSO2-DDE, 3,3’-(bis)MeSO2-DDE and o,p’-DDD suppressed testosterone, estradiol and 
progesterone synthesis in LH-stimulated neonatal porcine Leydig cells in a concentration-
dependent manner. No detectable levels of cortisol were obtained. The results suggest an 
inhibitory effect of all three compounds on Leydig cell testicular steroid hormone production. 
The reduction in progesterone secretion as well as testosterone and estradiol might indicate 
that the compounds inhibit Leydig cell steroidogenesis cascade upstream.  
Overall, the expression of genes involved in Leydig cell steroidogenesis was decreased by the 
three test compounds, although one gene was up-regulated following 3,3’-(bis)MeSO2-DDE 
exposure. The compounds reduced expression of slightly different genes, and the results 
might indicate a more potent reduction following o,p’-DDD exposure compared to 3-MeSO2-
DDE and 3,3’-(bis)MeSO2-DDE. The decreased expression of some genes in the exposed 
Leydig cells might be associated with the reduced synthesis of steroid hormones observed at 
the same concentration.  
The potential endocrine disruption of 3-MeSO2-DDE, 3,3’-(bis)MeSO2-DDE and o,p’-DDD 
on Leydig cell steroidogenesis might be of concern as Leydig cells play a crucial role for male 
reproductive function and development by the secretion of testosterone and estradiol.  
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6. Future perspectives 
The variation between the experiments is a consequence of working with primary cell 
cultures, and further replicates should be included for more conclusive results. An additional 
gene important for testosterone synthesis, HSD17B3, could be included to the gene expression 
assay.  
To investigate the mechanisms behind the suppression of Leydig cell steroidogenesis induced 
by 3-MeSO2-DDE, 3,3’-(bis)MeSO2-DDE and o,p’-DDD, further studies are needed. 
Previous studies in adrenal cells suggest steroidogenic disruption by the compounds caused 
by interaction with steroidogenic enzymes at the protein level. Therefore, the inhibitory effect 
on Leydig cell hormone production by the compounds might involve interaction at the protein 
level and possible alterations in enzyme activity could be interesting to investigate.  
The suppression of Leydig cell steroidogenesis might involve inhibition of LH-stimulation 
following exposure to the compounds, therefore intracellular cAMP levels could be measured 
in exposed and control cells. Inhibition of the mitochondrial electron transport chain might 
suppress Leydig cell steroidogenesis, hence the compounds effect on mitochondrial function 
could be investigated.  
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8. Appendix 
8.1 Chemicals  
Chemical Producer 
3-MeSO2-DDE  Synthelec AB, Ideon, Lund, Sweden 
3,3’-(bis)MeSO2-DDE Synthelec AB, Ideon, Lund, Sweden 
o,p’-DDD Sigma-Aldrich, Stockholm, Sweden 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich AS, Oslo, Norway 
LH (tuenre.pLH.ig,) Tucker Endocrine Research Institute, Atlanta Georgia, USA 
ITS + Premix BD Biosciences via VWR, International AS, Oslo, Norway 
NuSerum BD Biosciences via VWR, International AS, Oslo, Norway 
Ham’s F-12 and Dulbecco’s Modified 
Eagles Medium supplemented with 1.2 
mg/ml sodium bicarbonate and 15 mM 
Hepes, pH 7.4 (500 ml) (DMEM/F12) 
Gibco, Invitrogen, Carlsbad, CA, USA 
Ham’s F-10 Nutrient mixture  Biological Industries, Israel 
Collagenase-dispase (500 mg) Vibrio alginolyticus/Bacillus polyxema, Roche Neuss, 
Germany 
Penicillin/Streptomycin/Neomycin (PSN) Invitrogen, Carlsbad, CA, USA 
Percoll (500 ml) Sigma-Aldrich AS, Oslo, Norway  
AlamarBlue Invitrogen, Carlsbad, CA, USA 
Diethylpyrocarbonate (DEPC) Sigma-Aldrich AS, Oslo, Norway 
M199 modified Earle’s salts Sigma-Aldrich AS, Oslo, Norway 
Fetal calf serum (FCS) Fisher Scientific, Pittsburgh, PA, USA 
Lidocain Haukeland Hospital Pharmacy, Bergen, Norway 
Ketoprofen Merial SAS, Lyon, France 
Trypsin EDTA Gibco Invitrogen, Carlsbad, CA, USA  
Nitro blue tetrozolium  Sigma-Aldrich AS, Oslo, Norway 
5-androstane-3β-ol-one  Sigma-Aldrich AS, Oslo, Norway 
NAD
+ 
 Sigma-Aldrich AS, Oslo, Norway 
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8.2 Preparation of Solutions and Media 
 
Collagenase/dispase stock 
For the collagenase/dispase stock 500 mg collagenase (Roche, Neuss, Germany) were 
dissolved in 10 ml of Ham’s F12 and Dulbecco’s modified Eagle’s medium (DMEM/F12). 
This produced a 100x collagenase stock solution (50 mg/ml), which were divided into 1 ml 
aliquots and stored at -20°C. 
Collection medium 
The collection medium was made from DMEM/F12 (500 ml) including 10 ml antibiotics 
penicillin, streptomycin and neomycin (PSN).  
Dissociation medium 
The dissociation medium was prepared on the day of use by mixing 75 ml DMEM/F12 
supplemented with PSN (10 ml PSN to 500 ml DMEM/F12) in a sterile flask. 2 ml aliquots of 
the collagenase/dispase (100x) stock were thawed and diluted with 8 ml of the DMEM/F12 
medium and 5 ml Fetal Calf Serum (FCS) were added. We filtered through a sterile 0.2 µm 
filter (VWR International AS, Oslo, Norway) and added to the remaining DMEM/F12. This is 
enough to digest about 30 testicles in a 500 ml flask. The dissociation medium was kept at 
4°C until use and put at 34°C water bath before the start of the testicle decapsulation.  
Complete plating medium 
The complete plating medium was prepared by taking 500 ml DMEM/F12 and adding 10 ml 
of PSN, 5 ml ITS + Premix and 12.5 ml NuSerum and stored at 4°C.  
Percoll solutions 
For preparation of the Percoll solutions with the required densities (for 12 gradients) we 
mixed 13 ml 10x Ham’s F10 nutrient mixture with 117 ml of undiluted Percoll which creates 
a Percoll 90% isosmotical solution (130 ml). 220 ml of DMEM/F12 and four labelled 50 ml 
sterile Falcon tubes is ready. To each tube the required amount of Percoll 90% and 
DMEM/F12 was added for the four individual Percoll dilutions (Table 8.1).  The Percoll 
dilutions were stored at 4°C until use and are sufficient to construct 12 gradients.  
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Table 8.1 Construction of Percoll solutions with the required amounts of Percoll 90% and 
DMEM/F12 (12 gradients). 
Solution (nr) Final density (%) Percoll 90% (ml) DMEM/F12 (ml)  
I 21% 24.5 82.1 
II 26% 18.1 45.8 
III 34% 40.5 66.1 
IV 60% 42.7 21.3 
  Total = 125.8 Total = 215.3 
 
8.3 Construction of Percoll discontinuous gradient 
A steady application of the solutions yields the most reproducible gradients. For each gradient 
we prepared a 50 ml tube and added 5 ml of the most dense Percoll solution IV (60%) to the 
bottom of the tubes (Figure 8.1). 7 ml of solution III (34%) in a 10 ml pipette is placed at the 
meniscus of the previous layer to form a liquid bridge and then we very slowly empty the 
pipette. Then a clean layer is formed on top of the previous one. This is repeated carefully 
with 5 ml of solution II (26%) and finally with 8 ml of solution I (21%). It is important that 
enough space is left at the top of the tube, which to pipette the 5 ml sample of the dissociated 
testicular cells.  
 
Figure 8.1: Making the Percoll discontinuous gradient. Each of the solutions (I-IV) was carefully 
added to a 50 ml tube to make the gradients. 
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